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Abstract
 
Transposable DNA elements constitute a class of discrete genome segments, which use 
fundamentally similar reactions for their movement within and between genomes. The 
similarity of the reaction mechanisms is re  ected by their enzymes, the transposases. 
Many DNA transposases share a conserved RNase H-like fold that contains a catalytic 
DDE motif. The bacteriophage Mu encodes MuA transposase, which is a well 
characterized member of the DDE transposases. Mu transposition proceeds within a 
nucleoprotein complex known as a transpososome, the core of which contains four MuA 
molecules and two synapsed transposon ends. The transpososome machinery in vivo 
involves auxiliary factors, but in vitro this minimal con  guration forms the basis of 
Mu transposon tools that are widely used in genetics/genomics applications. In spite of 
a detailed knowledge of the chemical reactions of Mu transposition and transposition 
mechanisms in general, structural information on transpososomes has proven elusive 
for most of the DNA elements. Structural studies of transposases and functional data 
provide an unparalleled insight into the mechanistic details of action. These studies are a 
prerequisite to the understanding of the important biological processes in which they are 
involved. They are also useful for the evaluation of exploiting DNA transposon as tools.
The present study expands the knowledge of the functional determinants of Mu 
transposition machinery. Important structure-function relationships of MuA were 
revealed. Initially, properties for successful random MuA mutant library generation were 
dissected by comprehensive evaluation of different random DNA mutagenesis methods. 
Analyses provided useful operational guidelines for generating diverse mutant libraries.
Next, a universal assay that quantitatively analyzes DNA transposition events 
was established for mutant screening purposes. The assay is based on the inducible 
expression of transposase, which catalyzes the transposition of a lacZ marker gene-
containing transposon. Individual transposition events can be scored as blue micro 
colonies or papillae growing within an otherwise whitish colony. The assay was 
validated by Mu and IS903 transposition systems.
The papillation assay was used to analyze MuA mutant libraries generated by two 
different approaches. First, a pentapetide insertion mutagenesis strategy was used to 
map MuA protein structure for those regions that withstood insertion without reduction 
of function. The comprehensive structure-function analysis was complemented with 
data from the sequence alignment of protein homologues and they yielded a wealth of 
information about the activity of the transposition machinery. In addition, potential sites 
for further protein modi  cations were identi  ed.
Second, different random MuA mutant libraries were screened for increased 
transposition frequency. MuA mutant variants with altered properties could be generated. 
Many single-amino acid substitution MuA mutants were tested by two different 
assays relevant for MuA-based applications. Several MuA mutants were discovered 
to be valuable for Mu in vitro transposition applications. In addition, the mapping 
of hyperactivity-inducing substitutions to the recently resolved Mu transpososome 
structure, allowed the factors behind the activity enhancement to be characterized. 
The results of this study provide a comprehensive structure-function map of 
MuA transposase. Mapping of insertion tolerant versus insertion intolerant sites and 
hyperactivity-inducing mutations of MuA structure in the context of the entire Mu 
transpososome, provides fundamental insights into the function of the transpososome. 
The functional information explains and validates different protein-protein and protein-
DNA contacts seen in the crystal structures. They may also provide suggestions for 
protein conformational changes that accompany the transposition process. Moreover, 
the activity enhancing substitutions discovered in RNase H-like fold may be generalized 
to generate hyperactive variants or used for mechanistic analyses of other DDE 
transposases or used for the analyses of their close relatives such as HIV integrase and 





Transposable elements (TEs) are discrete segments of DNA that can either move or be copied 
from one genomic site to another within and between genomes. They use special type of 
recombination called transpositional recombination or transposition for their movement that 
is independent of target DNA homology (reviewed by Craig et al., 2002). The transposable 
elements were discovered by Barbara McClintock, who demonstrated their role in changing 
the structure of the maize chromosome in the 1940’s (reviewed by McClintock 1987). The 
new concept of genomes as dynamic and  uid entities were received with skepticism and 
these “jumping genes” were long ignored and called “sel  sh” or “junk” DNA (reviewed by 
Plasterk, 1995).
Today, the diverse transposable elements have been identi  ed in all kingdoms of life 
(reviewed by Campbell, 2002; Feschotte et al., 2002; Filee et al., 2007; Gregory, 2005; 
Siguier et al., 2006a) and in the genomes of virtually every organism sequenced. TEs are 
widely accepted important components of genomes and signi  cant contributors of genome 
evolution (reviewed by Goodier and Kazazian, 2008; Kidwell and Lisch, 2001; Lisch, 
2012; Pritham, 2009). They are present in different diversity and copy numbers ranging 
from just a few elements to tens or even hundreds of thousands per genome (reviewed by 
Biemont and Vieira, 2005). The number of identi  ed TEs is continuously increasing due to 
ongoing genome sequencing projects. For the simplest prokaryotic TEs alone, more than 
3000 annotated examples are presently known (Siguier et al., 2006b; see IS  nder; www-is.
biotoul.fr/is.html). TEs are abundant within the eukaryotic genomes. For example, about half 
of the genome in humans (Lander et al., 2001) is composed of TEs. In contrast to the high 
proportions found in large genomes, small genomes tend to have a low proportion of TEs 
(reviewed by Campbell, 2002; Gregory, 2005). 
The parasitic lifestyle of TEs has required certain constrains for long-term evolutionary 
survival (reviewed by Brook  eld, 1995; Brook  eld, 2005). TEs need to strictly recognize 
the border between themselves and their host DNA and perform events that result in their 
own spread within the host genome (reviewed by Plasterk, 1995). For sel  sh propagation 
TEs encode enzymes specially dedicated to the task. Furthermore, TEs have to be able to 
replicate faster than the host cell but regulate their transposition to avoid self-destruction 
through host cell death (reviewed by Plasterk, 1995). 
1.1.1 Impact on genomes
Although TEs in genomes are mostly ancient and inactivated by truncations or 
rearrangements, some active elements cause new insertions that are most likely benign, 
very occasionally harmful, and with extreme rarity bene  cial (reviewed by Goodier and 
Kazazian, 2008; Gray, 2000). TEs have not only in  uenced strongly on the evolution of 
their host genome but also co-evolved with their hosts (Kidwell and Lisch, 1997; reviewed 
by Feschotte, 2008; Jurka et al., 2007). When TE insertion confers a selective bene  t to 
the host, it is said to be domesticated. The co-option of TE sequences, their enzymatic 




organisms (reviewed by Brook  eld, 2005; Feschotte and Pritham, 2007; Muotri et al., 2007; 
Oliver and Greene, 2009; Volff, 2006). One of the most studied example of domesticated 
TE enzyme is RAG1 endonuclease, which performs V(D)J recombination, a process that 
generates adaptive vertebrate immune system by assembling immunoglobulin and T-cell 
receptor genes (reviewed by Gellert, 2002). In prokaryotes, TEs may carry and spread a 
variety of genes involved in accessory cell functions, such as resistance to antimicrobial 
agents (reviewed by Bushman, 2002). 
The dynamic co-evolutionary interaction between TEs and the genomes in which they 
reside have had a key role in the evolution of eukaryotic gene regulation (reviewed by 
Feschotte, 2008; Oliver and Greene, 2009; Rebollo et al., 2010; Zamudio and Bourc’his, 
2010). TEs encode mechanisms for controlling their own DNA transfer and also organisms 
have evolved complex mechanisms to control activity of TEs (reviewed by Brook  eld, 2005; 
Bushman, 2002; Fedoroff, 2002; Nagy and Chandler, 2004; Pritham, 2009). Therefore far 
beyond being junk DNA, TEs have proven to be natural genetic engineering systems and 
major evolutionary driving forces with important biological implications (Shapiro, 2010).
1.1.2 Classi  cation of elements
The abundance and extreme diversity of TEs has challenged and confused their classi  cation. 
However, the major distinguishing feature of TEs is whether their transposition includes an 
RNA intermediate (Class I) or transposition relies exclusively on DNA intermediates (Class 
II) (reviewed by Finnegan, 1989). These two classes of TEs can further be subdivided into 
separate subclasses, orders and superfamilies on the basis of the transposition mechanism, 
sequence similarities and structural relationships (reviewed by Wicker et al., 2007). Both 
classes of elements include autonomous elements that encode their own transposition 
machinery and non-autonomous elements that rely on autonomous elements in their 
transposition.
1.1.2.1 Class I elements
Class I elements use an RNA intermediate in transposition (reviewed by Boeke and Stoye, 
1997; Finnegan, 1990). The genomic element is transcribed into an RNA intermediate 
by RNA polymerase and reverse-transcribed into DNA by an element-encoded reverse 
transcriptase (RT) (reviewed by Boeke and Stoye, 1997; Finnegan, 1990). Class I elements 
(retroelements or retrotransposons) use transposition mechanism, in which element 
is not excised from the donor molecule but each complete replication cycle produces 
complementary DNA (cDNA) copy of the element into a new target site (reviewed by 
Beauregard et al., 2008; Jurka et al., 2007; Pritham, 2009; Wicker et al., 2007).
Classically, retrotransposons are divided by the presence or absence of long-
terminal repeats (LTRs) to LTR retrotransposons and non-LTR retrotransposons. LTR 
retrotransposons reverse transcribe retroviral RNA into cDNA copy within the viral particle 
and insert cDNA into the host chromosome involving an association of an integrase enzyme. 
Endogenous retroviruses residing in genomes belong to the group of LTR retrotransposons. 
The abundance of LTR retrotransposons is usually low in fungi, highly variable in animals, 
and high in plants (reviewed by Beauregard et al., 2008; Jurka et al., 2007; Pritham, 2009; 
Wicker et al., 2007).
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Non-LTR retrotransposons often encode endonuclease, which produces a nick in 
the target DNA that serves as a primer for reverse transcription of their genome. Reverse 
transcription and integration occur through a coupled process termed target-primed reverse 
transcription (reviewed by (Beauregard et al., 2008). The most prevalent examples of non-
LTR retrotransposons are LINEs and SINEs (long and short interspersed elements). LINEs 
encode proteins for their mobilization, but SINEs are nonautonomous elements and require 
LINEs for their propagation. Non-LTR retrotransposons are highly abundant in eukaryotes; 
especially in mammals (reviewed by Goodier and Kazazian, 2008). 
Novel retrotransposons are identified that differ from both LTR and non-LTR 
retrotransposons (reviewed by Beauregard et al., 2008). One is DIRS-like elements 
(Dictyostelium intermediate repeat sequence) which are  anked by unusual termini and 
they encode a tyrosine recombinase instead of integrase enzyme (reviewed by Goodwin and 
Poulter, 2001; Goodwin and Poulter, 2004). The second is Penelope-like elements, which 
have LTR-like termini or are 5’-truncated (Evgen’ev et al., 1997; reviewed by Evgen’ev and 
Arkhipova, 2005). These elements appear to transpose via target primed reverse transcription 
similar to non-LTR retrotransposons (reviewed by Beauregard et al., 2008).
1.1.2.2 Class II elements
Class II elements (DNA transposons) transpose directly as DNA, utilizing either double- or 
single-stranded DNA intermediate (reviewed by Feschotte and Pritham, 2007; Mizuuchi, 
1992b). DNA transposons are found in all kingdoms of life but are particularly prevalent in 
bacteria. DNA transposons are composed of speci  c sequences that de  ne the ends of the 
element and  ank an open reading frame (ORF) encoding a catalytic enzyme, the transposase 
(Figure 1.). Typically transposon end sequences are in inverse orientation (terminal inverted 
repeats, TIRs) (reviewed by Mahillon and Chandler, 1998; Mizuuchi, 1992b). For their 
movement, most DNA transposons use a strand exchange mechanism involving excision 
and reinsertion of an element, but some DNA elements use replicative transposition (chapter 
1.2.2). 
1.1.2.2.1 Prokaryotic elements
DNA transposons range widely in size and complexity in bacteria (Figure 1.). The simplest 
prokaryotic DNA elements are insertion sequences (ISs) consisting of two short TIRs 
 anking a single, or sometimes two, short open reading frames encoding a transposase. More 
genetically complicated elements are composite transposons, which are composed of a pair 
of IS elements that bracket additional genetic information for antibiotic resistance or other 
properties (for example Tn5 and Tn10). Complex transposons do not have embedded ISs but 
may encode for several proteins (for example Tn7). Most intricate elements are transposing 
bacteriophages encoding an extensive set of proteins necessary for their viral life-style (for 
example phage Mu).  Conjugative transposons exhibit hybrid properties of transposons, 
plasmids, and bacteriophages (for example Tn916) (reviewed by Bushman, 2002; Craig et 
al., 2002). The simple ISs are small; generally shorter than 2.5 kb, but complex bacteriophage 




Most DNA transposons identi  ed in eukaryotes are quite similar to classical prokaryotic ISs 
(Figure 1.). DNA transposons in eukaryotes can be divided in three subclasses depending 
on their transposition mechanism: classic “cut-and-paste” transposons, rolling-circle 
mechanism utilizing Helitrons, and self-replicating Mavericks (also known as Polintons) 
(reviewed by Feschotte and Pritham, 2007; Wicker et al., 2007; Yuan and Wessler, 2011). 
“Cut and paste” transposons can be further subdivided, primarily on the basis of sequence 
similarity of the transposase, into 19 currently recognized superfamilies (see Repbase (Jurka 
et al., 2005); http://www.girinst.org/repbase/index.html) of which the most studied are hAT, 
Tc1/mariner, P, PiggyBac, and PIF/Harbinger elements. Class II elements include also non-
autonomous derivatives called MITEs (miniature inverted-repeat transposable elements) that 
are composed simply of terminal IRs and a small non-coding DNA segment (reviewed by 
Feschotte et al., 2002).
1.1.3 Transposon tools
In addition to their basic biological interest, transposons have been used as diverse molecular 
tools in prokaryotes and eukaryotes during the last three decades. Transposon applications 
are based on harnessing the inherent features of TEs in catalyzing their own insertion 
into variable target sites and performing breaking and rejoining of DNA. The ability of 
transposons to produce random insertion mutations ef  ciently into various genomic sites 
Figure 1. Examples of different 
DNA transposons and their end 
organization (not to scale). A) DNA 
transposons are composed of speci  c 
sequences that de  ne the ends of the 
element designated to the Left End 
(LE) and the Right End (RE). At each 
transposon end (gray rectangles), 
there are either single inverted repeat 
or a mix of terminal inverted repeats 
(TIRs) (black arrows). Different types 
of prokaryotic transposons are: B) 
insertion sequences (ISs), C) composite 
transposons, D) complex transposons 
(in Tn7 antibiotic resistance cassettes 
are part of an integron element), and 
E) bacteriophage using transposition 
(Bacteriophage Mu has two genes 
involved in transposition, A and B 
(bold)). Other genes are related to non-
transposition functions (Morgan et al., 
2002). F) Eukaryotic DNA transposons 
are similar to prokaryotic ISs. Drawn 
according to Craig et al., 2002.
5
Introduction
and potentially alter gene expression is widely exploited both at a genomic level and in 
the analysis of individual genes and proteins. Traditional transposon applications depended 
on transposition reaction in vivo, but the increasing understanding on transposition 
mechanisms promoted their in vitro use (reviewed by Berg and Berg, 1995; Hamer et al., 
2001; Hayes, 2003; Kaiser et al., 1995; Mizuuchi and Baker, 2002). In vivo transposition 
relies either on an endogenous transposon residing in the host chromosome or introduction 
of plasmid containing transposon (study II). For in vitro applications, transposition reaction 
is performed with puri  ed components in the test tube, after which the mutated DNA can 
be transferred into the host cells for further analysis. In their most uncomplicated format, 
in vitro transposition reaction can be reproduced in a simple reaction buffer using only 
transposon terminal inverted repeats, puri  ed transposase, and the DNA target substrate 
(reviewed by Hayes, 2003). Combination of in vitro and in vivo approaches involves initial 
assembly of transposition complexes in vitro and delivery into cells, where transposon DNA 
is integrated into the genome (reviewed by Hayes, 2003). The in vitro conditions overcome 
several limitations present in traditional in vivo systems, e.g. host-range limitations are 
avoided (reviewed by Hamer et al., 2001; Mizuuchi and Baker, 2002; Reznikoff, 2008). 
Transposon-based approaches are simple and highly ef  cient tools for genomics and 
proteomics studies, and are routinely used in prokaryotes, plants, and invertebrates but 
recently also in vertebrates including human cell lines (reviewed by Berg and Berg, 1995; 
Hayes, 2003; Ivics et al., 2009; Ivics and Izsvák, 2010; Kahlig et al., 2010; Kaiser et al., 
1995; Ni et al., 2008). Some of the most feasible for application purposes are the bacterial 
systems Mu, Tn5, Tn7, Tn10 and Tn552 as well as the eukaryotic piggyBac and molecularly 
reconstructed forms from ancient inactivated Tc1/mariner family elements Sleeping Beauty 
and hAT family element Tol2 (reviewed by Grabundzija et al., 2010; Hayes, 2003; Ivics and 
Izsvák, 2010; Mizuuchi and Baker, 2002). Minimal requirements for transposon sequence 
are transposon ends, which contain transposase binding sites essential for mobilization of 
DNA between them. Therefore, for different purposes transposon can easily be engineered 
to carry any desired genes between transposon end sequences, e.g. different selectable 
marker genes, reporter genes, sequencing primer binding sites, sequences for site-speci  c 
recombination systems, controlling elements such as promoters, transcription termination 
signals, polyadenylation sequences, splice acceptors, or replication origins (reviewed by 
Berg et al., 1989; Berg and Berg, 1995). 
In addition to their use as tools for analyzing functions of individual genes and their 
products, transposons have been used in genome-wide insertional mutagenesis projects 
(reviewed by Berg and Berg, 1995; Hamer et al., 2001; Hayes and Hallet, 2000; Hayes, 
2003; Kaiser et al., 1995; Mizuuchi and Baker, 2002; Singh et al., 1997). Insertional 
mutagenesis using transposon disrupts and manipulates genes on a genome-wide scale 
enabling high-throughput functional studies of genes associated with various biological 
pathways. These types of studies have become especially valuable after completion of 
extensive whole-genome sequencing projects (reviewed by Judson and Mekalanos, 2000). 
Transposon insertions are widely applied also in other types of molecular tools, such as 
for sequencing strategies (Adey et al., 2010; Gertz et al., 2012; reviewed by Hayes, 2003; 
Mizuuchi and Baker, 2002) and various protein engineering applications (reviewed by 
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Hayes and Hallet, 2000; Hayes, 2003; Mizuuchi and Baker, 2002), and also to identify 
cancer causing genes and tumor suppressors (Copeland and Jenkins, 2010). The current 
developments portray transposon tools productive for gene delivery for different organisms 
and modi  cation also vertebrate genomes (reviewed by Hamer et al., 2001; Ivics et al., 2009; 
Ivics and Izsvák, 2010; Miskey et al., 2005).  Because transposon-based vectors can be 
used for stable genomic integration in regulated and highly ef  cient manner, transposons are 
indispensable tools for generation of transgenic cells in tissue culture and in production of 
germline transgenic animals for basic and applied research (reviewed by Ivics et al., 2009; 
Ivics and Izsvák, 2010). Transposon systems have been used for modi  cations of human 
embryonic stem cells (hESCs) and reversible production of induced pluripotent stem cells 
(iPSCs) (reviewed by Nieminen et al., 2010; O’Malley et al., 2009) making transposons 
attractive vehicles in therapeutic somatic gene transfer in humans (reviewed by Hackett et 
al., 2010). For these purposes, the main limitation has been the low transposition ef  ciency, 
which has been tried to overcome by hyperactive transposase constructs (Doherty et al., 
2012; reviewed by Hackett et al., 2010). Furthermore, the ongoing investigations on TEs are 
expected to lead to the development of novel transposon technologies for genetic and cell 
engineering.
1.2 DDE transposons
DDE transposases are ubiquitous and represent the majority of characterised transposases, 
whose overall catalytic mechanism has been characterised in detail (Mizuuchi, 1992a; 
reviewed by Mizuuchi, 1992b). Members of the DDE transposase family carry a conserved 
triad of acidic residues –a DDE motif. The three acidic residues are crucial in the coordination 
of divalent metal ions required for catalysis (Kulkosky et al., 1992). The abundant DDE 
transposase family includes prokaryotic insertion sequences (ISs), members of the Tn3 
family of transposons, the Tn7, Tn5 and Tn10 families and transposable bacteriophages such 
as phage Mu (Nagy and Chandler, 2004, reviwed by Craig et al., 2002) and eukaryotic “cut 
and paste” transposons (Jurka et al., 2005; Yuan and Wessler, 2011). The family can also be 
extended to include retroviruses such as HIV, which encodes a catalytic integrase protein 
similar to the DDE transposases (Dyda et al., 1994; Haren et al., 1999; Rice et al., 1996; Rice 
and Baker, 2001). 
Despite the vast variety of transposons, certain basic features of transposition are 
shared among elements, although the detailed translocation mechanisms are element-
speci  c (reviewed by Curcio and Derbyshire, 2003; Dyda and Hickman, 2008; Hickman 
et al., 2010; Mizuuchi, 1992b; Turlan and Chandler, 2000). The process of transposition 
can be divided into a series of conceptually simple steps (reviewed by Craig, 1995; Craig 
et al., 2002; Grindley et al., 2006; Plasterk, 1995). In all transposons, the element-speci  c 
transposase protein recognizes and binds to the recombination sequences most commonly 
at the transposon termini. Transposase synapses the two element ends as a multimer and 
assembles into a high-order protein-DNA complex. Within the complex transposase 
catalyzes a set of chemically similar reactions at the ends of a transposon, the breakage 
and formation of phosphodiester bonds are called a donor DNA cleavage and DNA strand 
transfer. Subsequent reactions ultimately attach the element DNA to the target DNA. Finally, 
the synaptic complex is resolved and the transposition products are released. 
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1.2.1 Chemistry of DDE transposition
The chemistry of transposition reaction is identical for all DDE transposons. Transposition 
reaction proceeds through a series of single-step, in-line nucleophilic attacks resulting in two 
or more sequential phosphoryl transfer reactions (reviewed by Mizuuchi, 1992a; Mizuuchi 
and Baker, 2002; Monta o and Rice, 2011). The nucleophilic groups used for cleavage and 
strand transfer are activated for catalysis by a two divalent metal ion mechanism (Nowotny 
et al., 2005; Nowotny and Yang, 2006; reviewed by Nowotny, 2009; Yang et al., 2006). Two 
divalent metal ions, which are usually Mg2+, assist the nucleophilic attack by orienting the 
reacting groups, lowering the pKas of the nucleophile and leaving group, and stabilizing 
the geometry and charge of the transition state (Nowotny and Yang, 2006; reviewed by 
Mizuuchi and Baker, 2002; Monta o and Rice, 2011). The DDE motif residues coordinate 
by chelation of the two assisting divalent metal ions (Kulkosky et al., 1992). The mechanism 
of DDE transposition reaction progresses without covalent enzyme-substrate intermediates, 
and it does not require external energy sources, because exchanging one high-energy 
phosphodiester bond for another conserves the energy. 
The two chemical reactions of transposition are mechanistically similar and logically 
catalyzed by the same transposase active site (Kennedy et al., 2000, reviewed by Monta o 
and Rice, 2011). Firstly, the transposon DNA is cleaved by hydrolysis of the 3’-terminal 
phosphodiester bond at each transposon end, in a nucleophilic substitution attack of OH 
from water on a phosphate. This donor cleavage reaction introduces a single-strand nick 
and exposes a free 3’-OH group at the ends of the element. Secondly, these two 3’-OH 
groups act as nucleophiles directly attacking the target DNA on new phosphodiester bonds 
at the insertion site. Concerted transposon integration involves a pair of transesteri  cation 
reactions at each 3’-end of transposon DNA to one 5’-end of the target DNA. Because the 
two strands of the target DNA are attacked normally of few base pairs apart, the inserted 
transposon is  anked by short single strands of the host. The DNA intermediate generated 
by transposition reaction cleavage and strand transfer is converted to  nal recombination 
product by cellular enzymes. After repair replication by the host enzymes, transposon is 
enclosed by short duplication of the target site. The length of the target site duplication 
depends on the staggered cut made during strand transfer (usually 2 to 9 bp) (reviewed by 
Craig, 1995).
1.2.2 Transposition mechanisms of DDE transposons
In spite of their shared transposition chemistry, DDE transposons use different mechanisms 
for their movement to new sites. Generally, transposition strategies can be divided in two 
types depending on whether the donor cleavage involves single strand or double strand 
DNA cuts at both ends of the element (see reviewed by Hickman et al., 2010; Turlan and 
Chandler, 2000). Thus, the transposon either remains bound to the  anking host DNA or is 
completely released from the  anking DNA. The outcome results in replicative or “cut and 
paste” transposition (Figure 2).
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1.2.2.1 Replicative transposition
Replicative transposition is used when the donor cleavage involves cuts only at the 3’-ends 
of the transposon and 5’-ends of the element remain linked to the  anking host DNA (Figure 
2A). Therefore, the strand transfer results in a fusion between the donor and target DNA 
molecules to form a branched structure, so-called Shapiro intermediate (Shapiro, 1979), in 
which each transposon end is joined to the donor by one strand and the target by the other. 
Replication of the transposon from forks created at both ends of the transposon results in 
formation of a composite structure called cointegrate containing both donor and target DNA 
joined by direct repeats of the element. Finally, cointegrate is resolved by recombination 
(site-speci  c or generalized) into the donor and recipient replicon each carrying a copy 
of the element. Replicative transposition can also be intramolecular that yields inversions 
and adjacent deletions (reviewed by Ahmed, 2009). Elements that transpose by replicative 
mechanisms include bacteriophage Mu (reviewed by Chaconas and Harshey, 2002) and 
members of the Tn3 (reviewed by Grindley, 2002) and IS6 families (reviewed by Chandler 
and Mahillon, 2002).
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Figure 2. DDE transposition mechanisms. All transposable elements (black lines) are mobilized 
by two common steps, a donor cleavage (indicated by small vertical arrows) and a strand transfer 
to the target (thin black lines). DDE-transposons either copy themselves using replicative “copy-
and-paste” mechanism (A) or use nonreplicative “cut-and-paste” mechanism for excision of 
a double-stranded copy of the element (B-E). In replicative transposition, only single strand 
cleavages are introduced to expose the reactive 3’-OH ends, which are subsequently joined to the 
exposed 5’-ends of the cleaved target DNA (thin black line). Replicative transposition produces 
a branched structure, which is replicated to yield cointegrate. In non-replicative transposition, 
different strategies are used for the second strand cleavage, either without hairpins (B, E) or via 
hairpin formation (C, D). Strand transfer is identical to all of the elements. Target cleaved in a 
staggered manner generates single strand gaps, which are repaired by host functions. Drawn 




Most DDE transposons employ a “cut-and-paste” mechanism (or conservative transposition, 
non-replicative transposition) for their movement, which involves double-stranded excision 
of an element from the donor molecule and reinsertion into a new target site (Figure 2B-E). 
Although the transposition reaction itself does not involve a replication step, transposon 
multiplies when element is moved from replicated to non-replicated DNA during 
chromosome replication, or when gap repair involves homologous gene conversion from 
sister chromatid (reviewed by Brook  eld, 1995). 
“Cut-and-paste” transposons have adopted a variety of strategies for cleavage of the 
second strand to liberate themselves prior strand-transfer (reviewed by Hickman et al., 
2010; Turlan and Chandler, 2000). Transposon Tn7 requires two different strand-speci  c 
exonucleases for excision: TnsB catalyzes cleavage of the 3’-end and TnsA cleavage of 
the 5’-end (Bolland and Kleckner, 1996; Figure 2B). Members of the eukaryotic Tc1/
mariner family transposons and related IS630 elements cleave the non-transferred strand 
 rst at several bases within the transposon and subsequently the second strand supposedly 
by direct hydrolysis of the transposase itself (Feng and Colloms, 2007; reviewed by Plasterk 
et al., 1999; Figure 2E). Another way for second strand cleavage has been evolved for the 
members of IS4 family, Tn5 (IS50), Tn10 (IS10), and eukaryotic PiggyBac superfamily 
(reviewed by Haniford, 2006; Reznikoff, 2008). They are excised in a three-step reaction 
involving a hairpin intermediate (Figure 2C). Hairpin is formed when a free 3’-OH group 
at cleaved transposons ends attacks the complementary strand instead of the target DNA. 
Hairpin formations result in the release of transposon from  anking DNA. In the third step, 
hairpin is hydrolyzed to regenerate the 3’-OH and 5’-phosphate ends, followed by the strand 
transfer to a target DNA molecule. Eukaryotic Hermes transposon (member of hAT family) 
has been observed to form the hairpins on the donor backbone ends instead of the excised 
transposon (Zhou et al., 2004; Figure 2D). Similar three-step mechanism is used to generate 
immunoglobin diversity in V(D)J recombination (reviewed by Gellert, 2002). 
However, conservative transposition and replicative transposition are not totally two 
independent mechanisms but rather alternative outcomes of the transposition reaction 
(reviewed by Ahmed, 2009). The switch from conservative transposition to replicative 
transposition has been reported for Tn5 (Ahmed, 1991; reviewed by Ahmed, 2009), Tn7 
(May and Craig, 1996), and IS903 (Tavakoli and Derbyshire, 2001). The choice between 
the two alternatives is dependent whether the free 3’-OH groups engage in strand-transfer 
before, or after, the formation and resolution of hairpins (reviewed by Ahmed, 2009). This in 
turn re  ects the relative ef  ciency of transposase to perform these two different processes at 
the 3’-OH ends. Thus, transposons using cut-and-paste transposition are ef  cient in hairpin 
formation. Hairpin formation also re  ects the necessity of protecting free transposon ends 
from degradation, which is avoided by the mechanism itself in replicative transposition 
(reviewed by Snyder and Champness, 2007).
1.2.3 Structure of DDE transposases
Several structural and functional studies have de  ned topological independent functional 
domains for DDE transposases (reviewed by Haren et al., 1999; Hickman et al., 2010; 
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Polard and Chandler, 1995; Rice and Baker, 2001). Although, transposases have signi  cant 
variation in size and number of the domains, their functional organization has a general 
pattern: sequence-speci  c DNA binding located at N-terminal region, the catalytic domain 
often localized toward the C-terminal end, and C-terminus may contain additional domains 
involved in a number of functions assisting transposition (reviewed by Haren et al., 1999; 
Hickman et al., 2010; Nesmelova and Hackett, 2010; Nowotny, 2009; Rice and Baker, 
2001). The increasing number of crystal structures of catalytic cores of several transposases 
have been solved for both the prokaryotic (MuA; Rice and Mizuuchi, 1995  and Tn5: Davies 
et al., 2000) and eukaryotic Hermes (member of the eukaryotic hAT superfamily: Hickman et 
al., 2005) and Mos1 (member of the eukaryotic Tc1/mariner family: Richardson et al., 2009) 
elements, which have de  ned the architecture of these enzymes and revealed a remarkable 
structural similarity of their catalytic core (Figure 3.). 
The DDE residues fold into a close proximity for catalysis in a structure called an 
“RNase H-like fold”, which was  rst identi  ed in Escherichia coli RNase H1 (Katayanagi et 
al., 1990; Yang et al., 1990). Same fold is shared by all of the members in the large family of 
polynucleotidyl transferases (reviewed by Hickman et al., 2010; Nowotny, 2009; Rice and 
Baker, 2001). The conserved RNase H-like fold is a three-layered / /  domain ( 1- 2- 3-
1- 4- 2/3- 5- 4- 5) with a central, mixed  ve-stranded -sheet (reviewed by Hickman et 
al., 2010; Nesmelova and Hackett, 2010; Nowotny, 2009; Rice and Baker, 2001; Figure 4.). 
The positions of the catalytic DDE/D residues are always on the same topological elements 
of the fold, with the  rst D in the middle of the  rst -strand, the second D is at the end of the 
fourth -strand or just after it, and the 
last E/D on the fourth -helix or just 
before it (reviewed by Hickman et al., 
2010; Nowotny, 2009). The  rst three 
strands of the -sheet are anti-parallel 
and the shorter fourth and  fth strands 
run parallel to the first strand. The 
most conserved -helix of the fold 
is located after strand three and runs 
across one face of the -sheet, where 
it stabilizes and reinforces the central 
-sheet (reviewed by Hickman et al., 
2010; Nowotny, 2009). 
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Figure 3. Ribbon diagrams of the 
aligned catalytic core structures of 
four DNA transposases and of HIV-1 
integrase (PDB: 1biu, 1bco, 2fzt, 1mus, 
and 2bw3). The active-site residues 
are coloured magenta. The insertion 
domains of Tn5 transposase and 
Hermes are shown in red. The  gures 
are rendered with PyMol.
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The RNase H-like fold can be 
disrupted by insertion of sequences 
of various length and structure, 
most often to occur between 5 and 
4 (reviewed by Hickman et al., 
2010; Nowotny, 2009; Figure 3). 
This region may have additional 
significance in the biochemistry of 
transposition (reviewed by Hickman 
et al., 2010). In particular, large 
insertion domains to this region have 
contributed to hairpin formation and oligomerization (Davies et al., 2000; Hickman et al., 
2005). Some transposases have also another sequence motif, a so called “YREK motif”. 
It is located on 4, where the E of the YREK motif is the same as that of the catalytic 
DDE motif (Rezsohözy et al., 1993). It is likely that Y, R, and K form contacts important to 
hairpin formation on the transposon ends (Naumann and Reznikoff, 2002). However, some 
transposons contain only the K (or R) of the YREK motif that seems also to be catalytically 
important (reviewed by Hickman et al., 2010; Reznikoff, 2008).
The catalytic core of DDE transposases is not conserved beyond an RNase H-like fold, 
and the domains outside the catalytic domain vary considerably (reviewed by Hickman et 
al., 2010). However, site-speci  c DNA binding is typically on separate domain or domains 
upstream of the catalytic domain. Sequence-speci  c DNA binding to transposon ends is 
carried out by various kinds of DNA-binding domains such as one  (IS911: Loot et al., 
2002) or two helix-turn-helix (HTH) domains (Tc1/Mariner family: Richardson et al., 2009; 
van Pouderoyen et al., 1997; Watkins et al., 2004), winged-helix domains followed by an 
HTH domain (bacteriophage Mu: Clubb et al., 1994; Clubb et al., 1997; Schumacher et 
al.,1997), or a non-standard helical domains (Tn5: Davies et al., 2000 and Hermes: Hickman 
et al., 2005). In addition, most DDE transposases contain domains downstream of the RNase 
H-like catalytic domain involved in various functions such as non-speci  c DNA contacts, 
multimerization and auxiliary protein binding.
Figure 4. Ribbon diagram of the RNase 
H-like fold of MuA (PDB 1bco). The 
central -sheet (with numbered strands) 
and the conserved -helix are shown in 
orange and green, respectively. More 
divergent parts are shown in gray. 
The active-site residues are coloured 
magenta. The figure is rendered in 
PyMOL.
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1.2.4 Transposition happens in context
1.2.4.1 Organization of transpososome
The multiple steps of transposition take place in the context of a large protein-DNA 
complex known as a synaptic complex or a transpososome, which contains transposon 
DNA ends synapsed by a multimer of transposase, and in some cases, accessory protein 
and DNA factors as well (Lavoie et al., 1991; Surette et al., 1987). Transpososomes are 
the elaborate molecular machineries of transposition, which provide a precise architecture 
within which the chemical reactions occur (reviewed by Gueguen et al., 2005; Hickman et 
al., 2010; Monta o and Rice, 2011). These higher-order complexes, which have multiple 
proteins bound to multiple sites, have also a high level of cooperativity in their assembly. 
The assembly is usually facilitated by DNA supercoiling and accessory proteins (reviewed 
by Chaconas and Harshey, 2002; Craigie, 1996b; Echols, 1986). The complex circuit of 
interactions leading to transpososome assembly varies remarkably among elements and 
ensures high level of speci  city (reviewed by Hickman et al., 2010; Nesmelova and Hackett, 
2010). 
The structural and functional core of transpososome is a multimer of transposase with 
monomeric units symmetrically positioned at each end of the element. Dimeric assembly 
has been observed for e.g. Tn5 (Davies et al., 2000), Tn10, Mos1 (Richardson et al., 2009) 
and the human Hsmar1 (Claeys Bouuaert et al., 2011) transposases, but MuA (Baker and 
Mizuuchi, 1992; Mizuuchi et al., 1992) and Mariner transposases Tc3 (Watkins et al., 2004), 
Sleeping Beauty (Izsvák et al., 2002), and human Himar1 (Lipkow et al., 2004) assemble into 
a tetramer. In addition, even hexameric assembly has been resolved for Hermes (Hickman et 
al., 2005). Transposition machinery of Tn7 is exceptional as it assembles into a heteromeric 
complex TnsABCDE containing  ve separate proteins with speci  c functions (Waddell and 
Craig, 1988). 
Transposases have been shown to form multimers through special multimerization 
domain (IS3 family: Loot et al., 2002 and Hermes: Hickman et al., 2005), or specific 
sequence regions (IS911: Haren et al., 1998) or protein-protein interactions between 
several DNA-binding domains present in a dipartite arrangement in which two small 
N-terminal domains are connected by a  exible linker (Mos1: Richardson et al., 2009 and 
Tc3 transposase: Watkins et al., 2004). However, while some transposases form multimers 
by themselves, other multimerize only upon binding to transposon DNA (MuA: Baker and 
Mizuuchi, 1992 and Tn5: Davies et al., 2000). In addition, many transposons (e.g. Mu, Tn10) 
involve assisting host factors essential for transpososome assembly, but some transposons 
require also additional DNA factors (e.g. Mu) or presence of target DNA (e.g. Tn7) (reviewed 
by Chaconas and Harshey, 2002; Craig, 2002; Reznikoff, 2002). Therefore, formation 
and stabilization of synaptic complexes is due to contribution of intertwined network of 
protein-DNA and protein-protein interactions of various protein and DNA components in the 
transpososome organization (Davies et al., 2000; Hare et al., 2010a; Monta o et al., 2012; 
Richardson et al., 2009, reviewed by Hickman et al., 2010; Monta o and Rice, 2011).
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1.2.4.2 Function of transposition machineries
Transpososomes are dynamic entities, which undergo staged conformational changes to 
accommodate the different steps along the transposition pathway (reviewed by Gueguen et 
al., 2005). The increasing stability of the transpososome as it evolves to a productive complex 
pulls transposition forward together in addition to product binding energy (Abdelhakim et 
al., 2010; Monta o et al., 2012; Yanagihara and Mizuuchi, 2003; reviewed by Chaconas 
and Harshey, 2002). The specialized nucleoprotein structures regulate biochemical reactions 
with high precision (reviewed by Craigie, 1996b; Echols, 1986). The particular arrangement 
of DNA and protein components in the transpososome is prerequisite for assembly and 
catalysis but transposition machineries also regulate frequency, precision, directionality, and 
mechanism of transposition (reviewed by Harshey and Jayaram, 2006; Yin et al., 2007). 
Control of activity is important to avoid undesirable reactions and assure coordination of 
the multiple distinct transposition reaction steps catalyzed by the same active site, which 
occupies sequentially the different phosphate groups (Kennedy et al., 2000; reviewed by 
Gueguen et al., 2005; Mizuuchi and Baker, 2002; Monta o and Rice, 2011). Recurring 
theme in the function of transposition machinery is that catalysis of transposition occurs in 
trans: the transposase subunit bound to one transposon end in the transpososome catalyzes 
the chemical steps on the other end of the transposon (Aldaz et al., 1996; Davies et al., 2000; 
Hare et al., 2010a; Monta o et al., 2012; Namgoong and Harshey, 1998; Richardson et al., 
2009; Savilahti and Mizuuchi, 1996). Therefore, the transpososome assembly is a crucial 
regulatory checkpoint of transposition reaction that retains transposase inactive until it is 
incorporated into a productive synaptic complex (reviewed by Craigie, 1996a; Mizuuchi et 
al., 1992). 
The mechanistic differences among diverse transposons are mediated by or through the 
transposition machineries (reviewed by Gueguen et al., 2005; Mizuuchi, 1992b). Structural 
features and accessory proteins of the transpososome sense and exert control in target DNA 
capture, target immunity, and resolution of transposition products (reviewed by Gueguen 
et al., 2005; Parks et al., 2009). In target engagement, transpososome assess new DNA 
molecules for potential insertion (reviewed by Craig, 1997). Most transpososomes choose 
their integration sites at random, but show some sequence level preference (as for Tn10/
IS10: Bender and Kleckner, 1992; Halling and Kleckner, 1982 and Mu: Haapa-Paananen 
et al., 2002; Haapa-Paananen et al., 2002). An exception is Tc1/mariner elements, which 
all integrate into the sequence TA (van Luenen and Plasterk, 1994). However, transposon 
insertions are directed into DNA sequence that can form particular conformation. For 
example, important in target DNA selection is target DNA bending for Tn10 (Pribil and 
Haniford, 2003), a triple-helical DNA structure for Tn7 (Kuduvalli et al., 2001; Rao et 
al., 2000) and DNA mismatches for Mu (Yanagihara and Mizuuchi, 2002). Additionally, 
replication fork has been shown as a preferred target for insertions (e.g. Tn7: Parks et 
al., 2009 and IS903: Hu and Derbyshire, 1998) and the nucleosome-free DNA region in 
eukaryotic cells (e.g. Hermes: Gangadharan et al., 2010, Mu: Liu et al., 2009; Paatero 
et al., 2008). Target site selection can be mediated by interactions with host factors (e.g. 
DNA replication processivity factor for Tn7: Parks et al., 2009) or different target selection 
proteins that require ATP to choose target DNA (e.g. TnsD and TnsE proteins for Tn7: Craig, 
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2002; Peters and Craig, 2001) and MuB protein for Mu (Adzuma and Mizuuchi, 1988) or 
using transposase itself (e.g. Tn10: Junop and Haniford, 1997; Sakai and Kleckner, 1997). In 
addition, some transposition systems prevent from insertion into itself or into close vicinity 
by the phenomenon called target immunity. In the case of Mu and Tn7, transposase (i.e., 
MuA and TnsAB, respectively) and ATP-dependent DNA binding protein involved in target 
capture (i.e., MuB and TnC, repectively) act together to perform target immunity (reviewed 
by Chaconas and Harshey, 2002; Craig, 2002). 
Consequently, the transpososome architecture provides a key to understand all of the 
attributes of transposition, how it happens and how it is regulated (reviewed by Gueguen 
et al., 2005; Harshey and Jayaram, 2006; Hickman et al., 2010; Monta o and Rice, 2011). 
Therefore, the three-dimensional relationships between the components of the transposition 
machinery and changes in their con  guration reveal important aspects of the transposition 
reaction (reviewed by Hickman et al., 2010; Monta o and Rice, 2011).
1.2.4.3 Transpososome structures
Despite the early success with crystallization of the catalytic cores and Tn5 transpososome 
structure (Davies et al., 2000), the detailed structure of transposition machineries for other 
elements remained elusive for a long time (reviewed by Harshey, 2012; Hickman et al., 2010; 
Monta o and Rice, 2011). 
The few DDE transposases, 
which have been structurally 
characterized as complexes 
with their DNA substrates, 
have provided important 
details of their mechanism 
of action. Comparison of the 
known three-dimensional 
structures of transpososomes 
has highlighted conservation 
of catalytic domains but 
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Figure 5. DDE recombinase – 
DNA complexes (PDB: 1mus, 
2fzt, 4fcy, and 3oso). DNA ends 
are red and blue, and target 
DNA (where included) black. 
Catalytic subunits are red and 
blue. For tetrameric complexes 
(Mu and PFV) other subunits 
are shown, pink and cyan. In 
the PFV intasome structure, 
only catalytic domain of the 
additional subunit was visible. 




diversity of architectures (reviewed by Dyda and Hickman, 2008; Harshey, 2012; Monta o 
and Rice, 2011; Figure 5). The crystal structures of prokaryotic Tn5 transpososome 
representing a synaptic complex at the stage following cleavage from donor DNA (Davies et 
al., 2000) and eukaryotic Mos1 transpososome poised for target capture and strand transfer 
(Richardson et al., 2009) were the  rst to open the detailed structural perspectives. The 
recently resolved crystal structure of Mu transposase in post-integration stage sheds more 
light on the DDE recombinase evolution (Monta o et al., 2012).  Furthermore, because 
the DDE family can be extended to include retroviruses, the crystal structures of prototype 
foamy virus (PVF) integrase in complex with its cognate viral DNA (Maertens et al., 2010) 
have gained mechanistic insights to functional complex organization in general.  
The overall architectures of the Tn5, Mos1, and Mu transpososomes and PFV intasome 
are remarkably different but they share several recurring features, which may re  ect con-
vergent evolution for functional reasons (Monta o et al., 2012; reviewed by Monta o and 
Rice, 2011). The overall architecture of Tn5 is a compact, approximately globular assembly, 
which contains transposase dimer bound to the two anti-parallel transposon ends (Davies 
et al., 2000; reviewed by Nesmelova and Hackett, 2010). The overall architecture of Mos1 
looks very different with a dimer of transposase extended to transposon DNA end sequences 
and bound by DNA-binding domains of transposase monomers in a parallel fashion (Rich-
ardson et al., 2009). The Mu transpososome and the PFV intasome contain a tetramer of 
recombinase and two parallel element DNA ends (Hare et al., 2010b; Maertens et al., 2010; 
reviewed by Cherepanov et al., 2011). These tetramers contain two functionally distinct pairs 
of protomer subunits (Monta o et al., 2012; reviewed by Cherepanov et al., 2011). The inner 
subunits of the tetramer are responsible for catalysis and the outer subunits seem to provide 
supporting functions (Hare et al., 2010b; Monta o et al., 2012; reviewed by Cherepanov et 
al., 2011).
Outside of the fundamental building block, RNase H-like fold, the structures 
of transposases vary greatly (reviewed by Hickman et al., 2010). Accordingly, the 
transpososomes structures are conserved only through their catalytic cores. All 
transpososomes are arranged to perform catalysis in trans, which ensures coordinated 
reactions at the element ends. Also the positions of the catalytic carboxylates and metal ions 
and the 3’-nucleotides within the active sites are conserved despite the divergence of the 
architectures (reviewed by Cherepanov et al., 2011). Other similarity in the transpososome 
architectures is the way complexes are maintained together via intertwined network of 
protein-protein and protein-DNA contacts, although underlining interaction networks are 
mediated by different domains (Davies et al., 2000; Monta o et al., 2012; Richardson et 
al., 2009; reviewed by Cherepanov et al., 2011). In transpososomes, transposon ends are 
bound bind by the HTH-motifs of the N-terminal binding domain (Tn5) or bipartite DNA-
binding domains (Mos1 and Mu), but they form divergent contacts in their respective 
transpososomes (Monta o et al., 2012; Richardson et al., 2009; reviewed by Monta o and 
Rice, 2011; Steiniger-White et al., 2004). Also the synaptic complex formation is mediated 
by multimerization using different protein segments and a divergent network of contacts 
(reviewed by Cherepanov et al., 2011; Dyda and Hickman, 2008; Monta o and Rice, 2011; 
Steiniger-White et al., 2004).
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Another common feature to transpososomes is target bending (Monta o et al., 2012; 
reviewed by Monta o and Rice, 2011). This is revealed by complexes containing the target 
(Maertens et al., 2010; Monta o et al., 2012). Furthermore, the target DNA can be modeled 
also onto the structures of Tn5 and Mos1 were it is presumed to adopt a bent conformation 
(Davies et al., 2000; Richardson et al., 2009). This feature is proposed to contribute to the 
irreversibility of the strand transfer reaction as the DNA is strained away from the active 
site after the reaction (Monta o et al., 2012). This may be the basis for the product binding 
energy that pulls transposition reaction forward (Monta o et al., 2012).
Comparison of the several synaptic complex structures has highlighted the divergent 
overall architectures, which reflects the structural differences of transposases and 
consequently diverse transposition mechanisms (replicative transposition for Mu, hairpin 
formation for Tn5 but not for Mos1), different spacing between attacks on the target 
DNA (5-bp for Mu, 9-bp for Tn5, and 2-bp for Mos1) and different regulatory details but 
convergent evolution for function (Monta o et al., 2012; reviewed by Hickman et al., 2010; 
Monta o and Rice, 2011; Nesmelova and Hackett, 2010).
1.3 Bacteriophage Mu
Bacteriophage Mu is both a transposable element and a temperate phage of Escherichia coli 
and other Gram-negative bacteria with the capacity to induce high rates of mutations, hence 
its name Mu (short for mutator) (Taylor, 1963). Mu is unique as a transposon and a phage, as 
while it uses two modes of transposition ef  ciently during the distinct stages of its life cycle: 
(i) to integrate its genome as a simple insert into the host DNA following infection and (ii) 
to replicate itself during the lytic growth of the host using replicative transposition (reviewed 
by Mizuuchi and Craigie, 1986). Although the initial Mu integration into the host genome 
results in a simple insertion (Akroyd and Symonds, 1983; Chaconas et al., 1983; Harshey, 
1984; Liebart et al., 1982), it is supposedly mainly an unusual outcome of the replicative 
transposition mechanism due to the differences in processing the transposition intermediates 
(Au et al., 2006; Choi and Harshey, 2010; Jang et al., 2012). 
Mu is with its 36,717-bp genome and 55 genes one of the most complex and elaborate 
transposition systems studied to date (Morgan et al., 2002; reviewed by Harshey and 
Jayaram, 2006; Figure 1E). However, the highly ef  cient transposition (Chaconas et al., 
1981) and development of the  rst de  ned in vitro transposition system of Mu (Craigie 
and Mizuuchi, 1985; Craigie et al., 1985; Mizuuchi, 1983) has made the Mu transposition 
a thoroughly characterized system and a paradigm of DNA transposition in general 
(reviewed by Chaconas and Harshey, 2002; Harshey, 2012; Mizuuchi, 1992b) even though 
Mu uses replicative mode of transposition, which is more of an exception than rule among 
transposons. The replicative Mu DNA transposition proceeds through a series of higher-
order nucleoprotein complexes termed Mu transpososome, which contain as a structural core 
a tetramer of Mu encoded transposase, MuA, bound to the two transposon ends (Lavoie et 
al., 1991; Surette et al., 1987). The assembly and function of Mu transposition machinery 
is a sophisticated process with an arsenal of cis and trans requirements for transposition 
(Baker and Mizuuchi, 1992; Craigie et al., 1985; Mizuuchi and Mizuuchi, 1993; Savilahti 
17
Introduction
et al., 1995; Yin et al., 2007). The chemical steps of transposition are catalyzed by MuA 
transposase, but other Mu encoded proteins, a number and intricate arrangement of phage 
encoded DNA sites, several host encoded proteins, and strict DNA topology requirements are 
involved in transposition (reviewed by Chaconas and Harshey, 2002; Harshey and Jayaram, 
2006).
1.3.1 DNA requirements in Mu transposition
The DNA structure at the ends of Mu genome is asymmetric with three MuA binding sites at 
each end (Craigie et al., 1984; Groenen and van de Putte, 1986; Zou et al., 1991; Figure 6A). 
The sparsely spaced binding sites at left end, designated L1, L2, and L3 are all in the same 
head-to-head orientation. The ~80 bp space between L1 and L2 contains a binding site for 
the DNA-bending protein HU (Lavoie et al., 1996). In contrast, the binding sites at the right 
end are closely spaced with R3 site in the opposite orientation of R1 and R2. The binding 
sites share a 22-bp consensus sequence, with no obvious internal symmetry (Craigie et al., 
1984; Zou et al., 1991). All six Mu end binding sites are required for optimal transposition 
but their relative importance for transposition varies as their MuA binding af  nity (Allison 
and Chaconas, 1992; Craigie et al., 1984; Kuo et al., 1991; Lavoie et al., 1991; Mizuuchi 
et al., 1991).  In addition to binding sites in transposon ends, a supplementary binding 
region for MuA and host cell proteins exists about 1 kb from the left end (Figure 6A). 
Figure 6. A)  Cis  and 
t r a n s  r e q u i r e m e n t s 
in  Mu t ranspos i t ion . 
Shown are genes A and 
B (bold) encoding MuA 
transposase and MuB 
protein, respectively. The 
substructures of the Mu left 
(L) end, internal activation 
s e q u e n c e  ( I A S )  i . e . 
enhancer region, and right 
(R) end are enlarged. Black 
vertical arrows denote the 
MuA binding sites L1 to 
L3 and R1 to R3, and the 
orientation and spacing of 
the consensus sequences 
within the sites, locations 
of L-end and R-end are 
numbered. Binding site for 
E. coli bending protein HU 
in L-end is shown. The upper enlargement show operator region (O1-O3), the location in L-end 
is numbered. It contains binding site for E. coli integration host factor (IHF). Drawn according to 
Morgan et al., 2001, Akhverdyan et al., 2011. B) Structural organization of MuA with different 
functions assigned to various subdomains (Roman Numerals ans Greek letters). The numbers 




Transpositional enhancer (E; O1-O3) or the internal activating sequence (IAS) is part of the 
operator region, which contains clusters of MuA-binding sequences that also bind the Mu 
repressor and between O1 and O2, a binding site for integration host factor (IHF) (Leung et 
al., 1989; Mizuuchi and Mizuuchi, 1989; Surette et al., 1989). The IAS promotes authentic 
transpososome assembly (Mizuuchi et al., 1992; Surette and Chaconas, 1992) and increases 
the ef  ciency of transposition (Leung et al., 1989; Surette et al., 1989). Also the terminal 
dinucleotide 5’-TG…CA-3’ of Mu is essential for stable transpososome assembly and 
transposition reaction (Burlingame et al., 1986; Goldhaber-Gordon et al., 2002a; Goldhaber-
Gordon et al., 2002b; Lee and Harshey, 2001; Lee and Harshey, 2003a; Lee and Harshey, 
2003b; Watson and Chaconas, 1996). The terminal dinucleotide is conserved among DNA 
transposons and assist DNA opening at the transposon termini prior transposition chemistry 
by allowing conformational  exibility (Lee and Harshey, 2001; Lee and Harshey, 2003a; Lee 
and Harshey, 2003b).
In addition to the three separate DNA sites, the Mu transpososome assembly requires 
negative supercoiling of Mu DNA to induce important conformational and torsional effects 
that are prerequisite for the speci  c geometry of the DNA segments within the productive 
synaptic complex (Mizuuchi and Craigie, 1986; Craigie and Mizuuchi, 1985; Craigie and 
Mizuuchi, 1986; reviewed by Chaconas and Harshey, 2002). DNA supercoiling assist 
speci  c MuA binding to end binding sites, but also binding of IHF to the IAS and HU to the 
spacer region between L1 and L2 (Kobryn et al., 1999; Surette et al., 1989). These accessor 
protein bindings induce precisely positioned DNA bends that brings distant MuA binding 
sites together to be linked by an oligomer of MuA (Lavoie et al., 1996). Additionally, the 
free energy of DNA supercoiling drives the conformational changes required for synapsis in 
general (reviewed by Chaconas and Harshey, 2002; Mizuuchi and Baker, 2002).
1.3.2 Organization of catalytic MuA transposase
MuA transposase is the catalytic enzyme of Mu transposon responsible for conducting all 
the chemical steps of transposition reaction. MuA is a 75-kDa protein (663 amino acids) and 
can be divided into structurally and functionally de  ned three major domains and several 
subdomains (Nakayama et al., 1987; Figure 6B). Structures of the  ve of its subdomains 
have been determined either by X-ray crystallography or by NMR (Clubb et al., 1994; Clubb 
et al.,997; 271 Schumacher et al., 1997, Rice et al., 1995) and recent Mu transpososome 
crystal structure reveals the architecture for nearly full-length MuA (Monta o et al., 2012; 
chapter 1.3.5.1 and Figure 5 and 7). The N-terminal DNA binding domain I participates in 
transposon end and enhancer DNA binding through separate regions. The small N-terminal 
subdomain I  contains a winged-HTH motif (Clubb et al., 1994) to bind the IAS and 
promote transpososome assembly (Leung et al., 1989; Mizuuchi and Mizuuchi, 1989). 
The speci  c Mu end-binding is mediated through two larger subdomains I  and I  both 
containing HTH motif, which recognize their own subsites in the ~50-bp MuA binding site 
(Clubb et al., 1997; Schumacher et al., 1997). Subdomains I  and I  of the monomeric MuA 
bind together over the two adjacent major grooves of a MuA binding site by using their 
respective recognition helices of a HTH motif and interacting with the intervening minor 
groove on the same face on the DNA with the linker that connects I  and I  (Monta o et al., 
2012; Schumacher et al., 1997; Zou et al., 1991).
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Following DNA-binding modules is the central domain II, which contains the catalytic 
subdomain II  associated at its C-terminus with a subdomain II  (Rice and Mizuuchi, 
1995). The catalytic subdomain II  contains the critical DDE-motif of acidic residues, at 
positions D269, D336 and E392, which are involved in the metal ion coordination during the 
catalysis (Baker and Luo, 1994; Krementsova et al., 1998). The divalent metal ion used in 
Mu reactions is Mg2+, although it can be substituted with several other cations in the distinct 
steps of the transposition pathway (Baker and Luo, 1994; Kim et al., 1995; Mizuuchi et al., 
1992; Wang et al., 1996). Subdomain II  forms a mixed /  domain and contain the RNase 
H-like fold: a central  ve-stranded mixed parallel and antiparallel  sheet, with helices on 
either side (reviewed by Rice and Baker, 2001; Figure 4). DDE motif residues of D269 
and D336 are located on adjacent strands of the  sheet, and the third, E392, is on a mobile 
loop that passes across the front of the sheet (reviewed by Rice and Baker, 2001). This 
con  guration of the E392 detected in the separate domain structure (Rice et al., 1995) is 
unable to coordinate two metal ion cofactors (reviewed by Hickman et al., 2010; Rice and 
Baker, 2001). It is suggested that this disordered loop become ordered upon DNA binding 
and fold into a regular -helical structure and become an upstream extension of 4 (Monta o 
et al., 2012; reviewed by Hickman et al., 2010). 
The subdomain II  forms a small, -barrel with a positively charged surface with 
non-specific DNA-binding activity (Nakayama et al., 1987; Rice and Baker, 2001). 
The involvement of subdomain II  in target and Mu DNA binding was evidenced in 
transpososome crystal structure (Monta o et al., 2012). Other functions have also been 
assigned for subdomain II  such as assisting in complex assembly and structural transitions 
(Krementsova et al., 1998; Monta o et al., 2012; Namgoong et al., 1994).
The C-terminal domain III can be divided into two subdomains. The positively charged 
subdomain III  was structurally uncharacterized before the resolved Mu transpososome 
structure, which depicted a long helical structure for subdomain III  (Monta o et al., 
2012). Subdomain III  participates in target DNA capture and non-speci  c DNA binding 
and structural transitions as subdomain II  (Baker et al., 1993; Krementsova et al., 1998; 
Monta o et al., 2012). Subdomain III  also displays cryptic endonuclease activity and may 
be associated with DNA-binding in Mu-host junction and nontransferred strand through 
the positively charged residues RRRQK, at positions 575-579. This region is proposed to 
remove the attached host DNA following the initial integration or deliver the uncleaved 
strand into active site for hydrolysis (Choi and Harshey, 2010; Monta o et al., 2012; Wu and 
Chaconas, 1995)
The C-terminal subdomain III  is responsible for interactions with other proteins that 
are regulators of transposition. Subdomain III  interacts with the phage-encoded MuB 
protein, a non-speci  c DNA binding protein with ATPase activity, which is important in 
targeting transposition into distal target sites (Baker et al., 1991; Hashey and Cuneo, 1986; 
Leung and Harshey, 1991; Wu and Chaconas, 1992). The carboxyl terminus of subdomain 
III  contains a binding tag for the host-encoded ClpX protein, which remodels the 
transpososome for disassembly before replication repair can occur (Levchenko et al., 1995).
All MuA subdomains are required for ef  cient phage Mu transposition in vivo but under 
some circumstances subdomains I  and III can be excluded. These include appropriately 
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altered DNA substrates and/or suitably modi  ed reaction milieu (Jiang and Harshey, 2001; 
Kim and Morrison, 2009; Krementsova et al., 1998; Mizuuchi and Mizuuchi, 1989; Yang et 
al., 1995). In the absence of enhancer, domain I  is even known to be inhibitory (Mizuuchi 
and Mizuuchi, 1989; Yang et al., 1995). 
1.3.3 Steps and nucleoprotein complexes in Mu transposition
Mu transposition starts with the binding of inert MuA monomers via their I  domains 
into three sites at each end of the Mu genome, which elicits the stepwise assembly of Mu 
transpososome containing MuA tetramer as a structural and functional core (Craigie et al., 
1984; Kuo et al., 1991; Zou et al., 1991; reviewed by Mizuuchi, 1992b). Initially, the binding 
of inert MuA monomers causes DNA bending at each site. Also the assisting host proteins 
(IHF, HU) induce precisely positioned DNA bends to promote the interactions among three 
DNA sites, the left (L) and right (R) ends of Mu, and enhancer element (E), present on 
supercoiled DNA (Kuo et al., 1991; Watson and Chaconas, 1996). This complex circuit of 
interactions through topological  lter leads to bridging interactions with the enhancer via I  
domains, initially E-R (enhancer – right end) crossings, which progress by DNA slithering to 
a transient three-site-synaptic complex LER, (left end – enhancer – right end) trapping  ve 
DNA supercoils (Pathania et al., 2002; Yin et al., 2007; reviewed by Harshey and Jayaram, 
2006). The DNA-protein and protein-protein interactions in LER activate tetramerization of 
MuA (Lavoie et al., 1991; Pathania et al., 2002; Pathania et al., 2003; Yin et al., 2005; Yin 
et al., 2007; reviewed by Harshey and Jayaram, 2006). Subsequently, the ordered pathway 
of transposition proceeds through formation of distinct tetrameric complexes with different 
con  guration and of increasing stability (Pathania et al., 2002, reviewed by Chaconas and 
Harshey, 2002; Figure 6). The enhancer remains weakly associated with the MuA also in 
tetrameric complexes, although it is not required for chemical steps (Surette and Chaconas, 
1992; Yin et al., 2005; Yin et al., 2007). A stable core of tetramer retains two L-R and one 
R-E DNA crossing (Yin et al., 2005; Yin et al., 2007, reviewed by Harshey, 2012). 
In the  rst tetrameric transposition complex the transposon ends are bridged to form the 
stable synaptic complex (SSC or type 0 complex) with all six MuA-binding sites occupied 
but only three sites (R1, R2 and L1) tightly bound (Kuo et al., 1991; Lavoie et al., 1991; 
Mizuuchi et al., 1991).  The MuA binding is extended into host DNA and DNA helix is 
opened at the transposon termini, which is the rate-limiting step of the cleavage reaction 
(Lavoie et al., 1991; Lee and Harshey, 2003a; Wang and Harshey, 1994; Wang et al., 1996). 
Within the tetramer, only the two MuA subunits located near the transposon termini (L1, R1) 
conduct the catalytic steps, whereas other two MuA subunits (bound to L2, R2) are essential 
for structural and functional integrity of the transpososome (Aldaz et al., 1996; Baker et al., 
1993; Mariconda et al., 2000; Namgoong and Harshey, 1998; Savilahti et al., 1995; Savilahti 
and Mizuuchi, 1996; Williams et al., 1999; Yang et al., 1995). The terminal nucleotides 
are engaged into the active site (Lee and Harshey, 2003a; Savilahti et al., 1995), which is 
organized to perform catalysis in trans (L1-bound subunit promote catalysis in R1 and vice 
versa) (Aldaz et al., 1996; Namgoong and Harshey, 1998; Savilahti and Mizuuchi, 1996). 
The domain sharing between monomers in the two active sites results in the interwoven 
architecture of the transpososome (Monta o et al., 2012; Yang et al., 1995; Yang et al., 1996; 
Yuan et al., 2005a; reviewed by Harshey and Jayaram, 2006).
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In the presence of Mg2+, the type 0 complex is quickly converted to type 1 complex 
or cleaved donor complex (CDC) as MuA subunits in L1 and R1 hydrolytically cleave the 
opposite Mu DNA ends at the terminal 3’-CA dinucleotides (Craigie and Mizuuchi, 1987; 
Mizuuchi, 1984; Surette et al., 1987). The exposed 3’-OH groups at the transposon ends 
are held in the active site, whose conformational changes upon target capture align the 
cleaved ends for strand transfer to occur. Target is delivered to the transpososome by an ATP-
dependent DNA-binding protein MuB through the interaction of C-terminus of MuA with 
an ATP-dependent DNA-binding protein MuB, which assembles into oligomeric clusters on 
DNA making MuB-bound DNA as an ef  cient transposition target (Baker et al., 1991; Han 
and Mizuuchi, 2010; Surette and Chaconas, 1991). Mu maximizes transposition potential by 
allowing target capture at varying steps of the transposition pathway, not only at the donor 
cleavage step (reviewed by Chaconas and Harshey, 2002). 
Short-lived type 1 complex is converted to type 2 complex or strand transfer complex 
(STC) when nucleophilic 3’-OH groups at transposon ends attack the phosphodiester 
bonds on target DNA of 5 bp apart, allowing simultaneous cleavage and joining through 
transesterification reaction (Mizuuchi and Adzuma, 1991). The most stable of the Mu 
transpososome is the type 2 complex, which contains the branched  structure or Shapiro-
type intermediate that will serve as a template for replication (Surette et al., 1987). However, 
this complex has to be actively disassembled before replication can occur. The complex 
is destabilized by unfolding of MuA subunit (either at L1 or R1) using host remodeling 
machine ClpX that interacts with the C-terminus of MuA (Abdelhakim et al., 2008; 
Abdelhakim et al., 2010; Jones et al., 1998; Kruklitis and Nakai, 1994; Kruklitis et al., 1996; 
Levchenko et al., 1995; Levchenko et al., 1997). The essential remodeling results in the 
formation of a fragile type 3 complex or STC2 complex that allows the recruitment of the 
host replication apparatus to resolve the branched strand transfer structure by target-primed 
replication, which results in formation of a cointegrate (Nakai et al., 2001). Ligation of the 
single-stranded gaps at the Mu-target junction by host factors completes a 5-bp duplication 
of the target site, considered as the hallmark of transposition (Allet, 1979; Kahmann and 
Kamp, 1979). 
1.3.4 Control of transposition
Without control, transposition would be detrimental to the host cell, and thus for the element 
itself (reviewed by Plasterk, 1995). Especially, while Mu replicates itself 100-fold during 
the lytic phase of its life cycle, it faces also a serious threat of self-destruction by inserting 
into itself (Bukhari, 1975). For its own good, Mu is one of the highly regulated transposon 
systems studied to date (reviewed by Chaconas and Harshey, 2002; Craigie, 1996a; Harshey 
and Jayaram, 2006). The Mu transposition is controlled at several levels. One way of control 
is the ordered interaction of the enhancer (ER, LER), which regulates transposition by 
specifying the architecture of MuA tetramer and DNA topology required for function of 
the transpososome (Yin et al., 2007). The enhancer has a role as a silencer when bound by 
lysogenic repressor c, which is homologuous to subdomain I  of MuA (Harshey et al., 1985). 
Repressor binding prevents MuA binding and thus transpososome formation (Mizuuchi and 
Mizuuchi, 1989). Vice versa, the involvement of enhancer as a part of the transpososome 
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prevents repressor binding and ensures commitment of transpososome to transposition 
(reviewed by Harshey and Jayaram, 2006). Repressor also negatively regulates transcription 
of the early gene products essential for the lytic growth, including MuA and MuB (Krause 
and Higgins, 1986).
Another way of control can be executed at the level of target site selection and avoiding 
Mu insertion into itself by a process called target immunity (or cis-immunity), both of 
which are mechanisms involving MuB, ATP and MuA (reviewed by Chaconas and Harshey, 
2002). At regional level, Mu integration is targeted to DNA bound by MuB protein, which 
has a modest preference for A/T-rich sequence (Manna et al., 2001; Maxwell et al., 1987; 
Mizuuchi and Mizuuchi, 1993; Naigamwalla and Chaconas, 1997). However, at sequence 
level Mu integrates essentially randomly, although some target sequence preference is 
statistically observed (5’-C-Py-G/C-Pu-G-3’) (Butter  eld et al., 2002; Haapa-Paananen et 
al., 2002; Mizuuchi and Mizuuchi, 1993). In addition, certain DNA deformations such as 
single-nucleotide mismatch are identi  ed as a hot spot for Mu integration (Yanagihara and 
Mizuuchi, 2002). 
In target immunity, MuB-ATP is bound to DNA at high-af  nity and interacts with Mu 
end-bound MuA (Greene and Mizuuchi, 2002a; Greene and Mizuuchi, 2002b; Maxwell et 
al., 1987). This interaction is achieved by the formation of DNA loops between the MuA- 
and the MuB-bound DNA sites (Adzuma and Mizuuchi, 1989; Greene and Mizuuchi, 2002c; 
Han and Mizuuchi, 2010). This interaction stimulates MuB ATPase activity resulting MuB 
to dissociate from the DNA (Mizuuchi and Mizuuchi, 1993). As a consequence, MuB 
removed from close vicinity of MuA accumulates on DNA far away from the Mu genome 
DNA and stimulates MuA to integrate Mu DNA to this selected distal site (10-15 kb away) 
(Schweidenback and Baker, 2008). However, an additional genome-immunity mechanism 
functional outside Mu ends has been proposed, where MuB is removed and bound strongly 
(Ge et al., 2010). In addition to these, MuB is also involved in transposition regulation 
by protecting transpososomes from a premature disassembly by the host chaperone ClpX 
(Levchenko et al., 1995). 
1.3.5 Mu transposition in vitro
The establishment of Mu in vitro transposition system method (Craigie and Mizuuchi, 1985; 
Craigie et al., 1985; Mizuuchi, 1983) has been essential for the comprehensive understanding 
of the Mu transposition. The initial in vitro reaction was performed with a supercoiled donor 
plasmid DNA carrying transposon ends in correct orientation, replication-competent E. coli 
extracts including host factors, and extracts containing MuA and MuB proteins (Mizuuchi, 
1983). Subsequently, the in vitro transposition reaction was re  ned further to contain puri  ed 
protein components, ATP, and divalent cation, which allow a more detailed dissection of 
reaction process (Craigie and Mizuuchi, 1985; Craigie et al., 1985). 
Finally, the relaxed topological requirements were permitted by addition of 
dimetylsulfoxide (DMSO) or glycerol either alone or in combination into the transposition 
reaction (Baker and Mizuuchi, 1992; Craigie and Mizuuchi, 1986; Mizuuchi and Mizuuchi, 
1989). This inclusion relaxed the need for DNA supercoiling and correct relative orientation 
of the Mu ends, as well as the presence of enhancer (Baker and Mizuuchi, 1992; Craigie 
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and Mizuuchi, 1986; Mizuuchi and Mizuuchi, 1989). Under these altered conditions also 
HU, IHF and MuB proteins and the enhancer-binding domain I  and the MuB-interacting 
domain III  of MuA could be omitted (Baker and Mizuuchi, 1992; Craigie and Mizuuchi, 
1986; Mizuuchi and Mizuuchi, 1989). Reaction pathway could be simpli  ed further by using 
precleaved donor DNA substrates, which allowed the ef  cient strand transfer to a target 
DNA but bypassed the cleavage step (Craigie and Mizuuchi, 1986; Craigie and Mizuuchi, 
1987; Mizuuchi and Mizuuchi, 1989). The minimal donor DNA sequence which allowed 
the most ef  cient catalysis was the pair of Mu R-ends containing the R1 and R2 subsites in 
inverted orientation (Baker and Mizuuchi, 1992; Craigie and Mizuuchi, 1987; Namgoong et 
al., 1994). They acted as allosteric effectors and promoted tetramerization of MuA through 
conformational changes (Namgoong et al., 1994).
Although several normal assembly requirements could be bypassed, the minimal Mu 
in vitro transposition faithfully reproduced the required chemical reactions and the stepwise 
assembly of the distinct tetrameric transpososome structures with increasing stability 
to conduct the transposition reaction (Baker and Mizuuchi, 1992; Savilahti et al., 1995). 
Therefore, Mu transposition reaction can be recapitulated in vitro under simple reaction 
buffer using only a precleaved donor DNA with short 50-bp R-ends or oligonucleotide 
substrates containing R-ends, MuA transposase and a target DNA as minimal macromolecular 
components (Haapa et al., 1999b; Savilahti et al., 1995). This minimal in vitro reaction has 
been extensively used for mechanistic studies of transpososome function and organization 
and used as a tool in various transposon applications (reviewed by Akhverdyan et al., 2011; 
Chaconas and Harshey, 2002; see below). 
1.3.5.1 Structure of the strand transfer complex
The Mu in vitro transposition reaction has facilitated crystallization of the long-awaited 
Mu transpososome structure in an active con  guration (Monta o et al., 2012). Crystallized 
structure of the  nal strand transfer complex contains a pair of Mu R-ends oligonucleotides 
each carrying R1 and R2 binding sites, tetramer of truncated MuA proteins, and a target 
DNA. The highly intertwined Mu strand transfer complex resembles a pair of scissors, 
where the Mu end DNAs form the handles and the target DNA the blades (Monta o et 
al., 2012; Figure 5 and 7). Similar V-shape for the Mu R-ends and MuA tetramer in type 
1 complex has also been proposed by cryo-electron microscopy reconstruction of Mu 
transpososome (Yuan et al., 2005a). Within the transpososome, MuA monomers bound to 
R2-ends envelop the inner R1-bound monomers of the same DNA segment, providing a 
structural role. Mu transpososome crystal structure con  rms many earlier predictions and 
biochemical results such as the complex circuit of macromolecular interactions underlying 
Mu DNA transposition, catalysis in trans with two active sites, and target interaction through 
II  subdomain, but also provides new explanations.
Structure of Mu transpososome contains only the central domains of MuA with the 
subdomains I  and III  omitted which are involved in enhancer binding and participate in 
MuB and ClpX interaction, respectively. However, the transpososome structure resolves a 
long helix structure for previously uncharacterized III  subdomain.  Most of the individual 
MuA subdomains have different functions in protomers bound to R1 versus R2 binding 
site. In R1 subunits III  subdomains pair to form a coiled coil structure, which curves in 
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the U-shape of the target anchoring 
it into the complex and stabilizing 
the strongly bent target. This target 
bending probably restrains reversibility 
of the strand transfer and is the basis 
of the product binding energy. This 
structural transition of the III domains 
upon target capture may be also the 
signal for ClpX remodelling machine. 
In R2 binding sites, subdomains III  of 
the separate DNA segments wrap horizontally around the other subunits now close to the 
active site and stabilize transpososome assembly. The Mu transpososome structure proposes 
that R2-bound III  subdomains interact also with the  anking host DNA.
DNA binding domains I  and I  bind the speci  c binding sites as con  rmed earlier 
(Namgoong et al., 1998; Zou et al., 1991). However, in the resolved transpososome, they 
have additional contacts only in R1 subunits, where I  has protein-protein contacts with 
III  domain of R2 in the same DNA segments and it contacts II  domain of R1 subunit 
on the other DNA segment. However, the modelling the structure provided a depiction for 
preferential complex assembly also in the natural context with all six DNA-binding sites, 
enhancer and DNA-bending protein HU involved. 
1.3.5.2 Applications of Mu technology
Minimal Mu transposition reaction has several features that make it ideal to be used in a 
variety of applications. Most importantly Mu can integrate into any target DNA with a high 
ef  ciency and a low target site-selectivity (Butter  eld et al., 2002; Haapa et al., 1999b; 
Haapa-Paananen et al., 2002; Mizuuchi and Mizuuchi, 1993; Savilahti et al., 1995). In 
addition, donor DNA can be custom-designed to include any DNA of variable length between 
the R-end sequences as well as the R-end sequences themselves can be moderately altered 
e.g. to contain restriction enzyme cutting sites, translational stop codons or adaptor regions 
(Brady et al., 2011; Goldhaber-Gordon et al., 2002a; Goldhaber-Gordon et al., 2002b; Haapa 
et al., 1999b; Jones, 2005; Laurent et al., 2000; Poussu et al., 2004; Poussu et al., 2005; Taira 
et al., 1999) further extending the application potentiality of Mu transposition system. Many 
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Figure 7 . Mu transpososome structure. 
Red versus blue subunits are on the 
opposite sides of the symmetry axis. 
Catalytic subunits red and blue are 
R1-bound. Additional subunit pink 
and cyan are R2-bound. Individual 
subdomains are shown (Roman numerals 
and Greek letters). Mu ends are red and 
blue, and target DNA black. Magenta 
spheres depict scissile phosphates. The 
 gure is rendered in PyMOL.
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Table 1. Current applications of Mu in vitro system
Application Use References
Delivery of primer 
binding sites
DNA sequencing Haapa et al., 1999a
DNA integration site recovery Brady et al., 2011
Linker insertion 
mutagenesis
Functional mapping of proteins Poussu et al., 2004
Deletion and substitution 
mutagenesis of proteins
Generation of nested sets of N- and 
C-terminal variants
Poussu et al., 2005
Deletion of single amino acids Jones, 2005
Substitution of single amino acids Baldwin et al., 2008
Protein domain insertion Edwards et al., 2008
Deletion and insertion of an arbitrary 
number of bases, scanning mutagenesis 
and site-saturation mutagenesis
Hoeller et al., 2008
Genetic footprinting Functional mapping of genome 
fragments, single genes or proteins
Laurent et al., 2000; 
Pajunen et al., 2007; 
Rothenberg et al., 2001; 
Weber et al., 2010
Functional mapping of viral genomes Kekarainen et al., 2002
Genome-wide 
insertional mutagenesis
Functional mapping of viral genomes Kiljunen et al., 2005; 
Krupovic et al., 2006; 
Vilen et al., 2003
Gene delivery by the 
use of preassembled 
transpososome 
complexes
Genome modi  cation in bacteria, yeast, 
or mammalian cells
Lamberg et al., 2002; 
Paatero et al., 2008; P
ajunen et al., 2005; 
Tu Quoc et al., 2007; 
Wu et al., 2009
Construction of targeting 
vectors for transgenic 
animals
Generation of null, potentially 
hypomorphic, and conditional alleles
Vilen et al., 2001
Generation of gene knockouts Zhang et al., 2005
Generation of gene knock-ins Jukkola et al., 2005
Generation of gene knockouts with 
plasmid-size vectors
Turakainen et al., 2009





different Mu transposition system applications are based on in vitro transposition reaction 
and introduction of the transposition products into appropriate cells to select integrants and 
to generate comprehensive libraries of mutant DNA molecules. The current Mu transposition 
applications include strategies for DNA sequencing, protein engineering, constructing gene-
targeting vectors, SNP discovery, genome-wide functional mapping and gene delivery (Table 
1). 
Speci  c modi  cation of transposon ends is exploited in designing novel transposon 
tools. For DNA sequencing application, transposon ends are used as a pair of primer binding 
sites. Transposon integration events produce primer binding sites randomly throughout the 
plasmid target and allow DNA sequence to be determined bi-directionally (Haapa et al., 
1999a). When transposon ends are engineered to contain adaptor regions complementary to 
PCR primers and an amine blocking group at the one DNA 3-end, Mu transposition can be 
used to substitute restriction enzyme cleavage and adaptor ligation (Brady et al., 2011). This 
method can be used in the  eld of human gene therapy to recover sites of integrated DNA 
by DNA barcoding and pyrosequencing (Brady et al., 2011). Similar strategy is applicable to 
construct DNA sequencing libraries for next generation sequencing platforms.
Mu in vitro transposition can be used in engineering of protein-encoding genes in 
order to study functional domains of proteins and protein-protein interactions. Mu in 
vitro transposition produces random in-frame transposon insertions into a plasmid target 
containing the cloned gene of study. For linker scanning mutagenesis, Mu transposon ends 
are modi  ed to contain NotI restriction site, which allows the elimination of transposon 
core sequence from the integration locus and leaving only a 15-bp insert. Within the 15-bp 
insertion, 10 bp is derived from the ends of the transposon used, and 5 bp from the duplicated 
target DNA at the insertion site. Translation of the insertions is dependent on the reading 
frame and the sequence at the insertion site.  The analysis of a large number of pentapeptide 
insertion mutants allows identi  cation of functional or essential protein regions and sites 
involved in protein-protein interaction as well as insertion tolerant sites (Pajunen et al., 2007; 
Poussu et al., 2004; Taira et al., 1999; study III). Similar strategy can be used to produce 
a nested set of N- or C-terminal deletion variants (Poussu et al., 2005). When the same 
restriction site is contained both in the transposon ends and at the start of the coding region 
of the target gene, N-terminally deleted fragments are produced after transposon integration 
and elimination of transposon and the N-terminal part of the target gene by digestion. 
C-terminally deleted variants can be produced with transposon containing stop codons in 
three different reading frames at the transposon ends. For deletion of three nucleotides at 
random positions in a target gene, Mu transposon ends were modi  ed to contain restrictions 
site for the type IIS restriction enzyme MlyI, which allows the elimination of transposon 
core sequence and 3-bp from the target gene (Jones, 2005). If the removed DNA segment 
is subsequently replaced with three new nucleotides, the reaction series produces random 
three nucleotide substitution (Baldwin et al., 2008). Same or similar strategy can be used 
to introduce a new protein domain (Edwards et al., 2008) and for deletion and insertion 
of an arbitrary number of bases, which allows scanning mutagenesis and site-saturation 
mutagenesis (Hoeller et al., 2008) and can be used for cancer gene discovery (reviewed by 
Copeland and Jenkins, 2010). These protein deletion and substitution strategies are useful in 
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protein engineering and structure-function studies of proteins (Baldwin et al., 2008; Edwards 
et al., 2008; Hoeller et al., 2008; Jones, 2005; Poussu et al., 2005).
Mu in vitro transposition reaction can be used for functional genetics or genomics of 
viruses by insertionally mutagenizing either complete or partial genomes cloned in a suitable 
vector or whole genomes to parallel identify non-essential and essential genes or regions 
of the genome involved in a biological process (Kekarainen et al., 2002; Kiljunen et al., 
2005; Krupovic et al., 2006; Vilen et al., 2003). Genome-wide insertional mutagenesis can 
be performed also by in vivo integration of in vitro assembled transpososomes into host 
genome (Lamberg et al., 2002; Paatero et al., 2008; Pajunen et al., 2005; Tu Quoc et al., 
2007; Wu et al., 2009).
Other types of applications that exploit Mu in vitro transposition are construction of 
several types of gene targeting vectors also as a plasmid-size vector to generate transgenic 
animals (Jukkola et al., 2005; Turakainen et al., 2009; Vilen et al., 2003; Zhang et al., 2005) 
and to discover single-nucleotide (SNP) polymorphism in DNA by exploiting the preference 
of Mu to target into mismatched DNA sites (Orsini et al., 2007; Yanagihara and Mizuuchi, 
2002). As well, novel applications are continuously in development.
1.4 Random DNA mutagenesis
Random mutagenesis methods are used to introduce genetic diversity throughout 
a cloned gene of interest in order to create mutant libraries sampling a large fraction of 
protein sequence. Random DNA mutagenesis followed by selection or screening provides 
a powerful strategy for protein engineering with an attempt to produce enzymes with 
improved functions and properties (reviewed Neylon, 2004; Wong et al., 2006; study I–IV). 
Directed protein evolution takes protein engineering further by imitating natural evolution 
in a reiterative cycle of genetic variation, phenotypic selection and genotypic ampli  cation 
aiming to improve enzyme  tness for a given application by altering protein function or 
evolving a new one (reviewed by Jäckel et al., 2008; Kaur and Sharma, 2006; Kumar and 
Singh, 2012; Yuan et al., 2005b). The genetic diversity introduced by random mutagenesis 
is also used to study protein structure-function relationships and functionally analyze 
uncharacterized open reading frames (reviewed by Neylon, 2004; study IV). Crucial for 
the success of these studies is the quality of the mutant library most commonly created by 
random mutagenesis method (reviewed by Dalby, 2011; Shivange et al., 2009; Wong et al., 
2006; Wong et al., 2007b; Wu et al., 2009). Traditional random mutagenesis methods can be 
classi  ed into categories depending on the method employed for nucleotide substitutions: 
chemistry- or cell-based and enzymatic methods as well as their combinations (Table 2). 
Classical chemical methods incorporate DNA modifying agents or DNA analogues into DNA 
and introduce mutations by incorrect replication or repair (reviewed by Grif  ths et al., 2000; 
Miller, 1992; Myers et al., 1985; Singer and Kusmierek, 1982). They are especially ef  cient 
when combined with enzymatic methods or used in oligonucleotide synthesis (reviewed by 
Murakami et al., 2003; Myers et al., 1985; Neylon, 2004; Singer and Kusmierek, 1982; Wu 
et al., 2009). Relaxing the high  delity of DNA replication is the basis of mutagenesis also in 
other methods (reviewed by Neylon, 2004). In cell-based mutagenesis the balance in DNA 
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replication can be confronted in addition to environmental/physiological stress by defects in 
one or several DNA repair pathway genes or with a lower  delity DNA polymerase (Camps 
et al., 2003; Greener et al., 1996; reviewed by Miller, 1992; Miller, 1996; Miller, 1998). 
These mutator strains allow easy mutagenesis by in vivo propagation of target DNA cloned 
in replicative vector (reviewed by Neylon, 2004). However, both the chemical mutagens 
and cell-based mutagenesis accumulate mutations also outside the target gene. These 
disadvantages are bypassed with enzymatic strategies exploiting DNA polymerase-based 
error-prone chain reaction (PCR) protocols. Error-prone methods are based on copy errors 
introduced by DNA polymerases with high error rate and/or reaction conditions imposing 
them further. The power of error-prone PCR has been behind the success of many directed 
protein evolution studies. However, it suffers the same challenges as chemical and cell-based 
methods. All of the methods are biased in terms of mutational spectra, which is assessed by 
the ratio of transitions (nucleotide substitution that change purine to purine or pyrimidine 
to pyrimidine) to transversions (nucleotide substitution that change purine to pyrimidine or 
pyrimidine to purine) (reviewed by Wong et al., 2006; study I). With enzymatic methods 
there are various efforts to overcome mutational bias such as varying the nucleotide ratio, 
adding nucleotide analogues, using engineered or natural less biased enzymes (reviewed 
by Shivange et al., 2009; Wong et al., 2006). However, all of the methods favor transitions 
over transversion with the outcome of more chemically conservative substitutions instead of 
chemically diverse substitutions (reviewed by Miyazaki and Arnold, 1999; Neylon, 2004; 
Shivange et al., 2009). 
Ideal circumstances would substitute every amino acid of a proteins sequence by its 
19 counterparts in a statistical manner (reviewed by Wong et al., 2006). Although random 
mutagenesis methods vary in terms of mutational bias, they introduce often only one 
nucleotide substitution in a codon. Because of the redundancy of the genetic code and 
organization to minimize mutations, random mutagenesis methods are able to reach only less 
than 40 % of all the possible changes in protein sequence (Miyazaki and Arnold, 1999; Wong 
et al., 2006; Wong et al., 2007b). Compared by simultaneous change of two consecutive 
nucleotides in a codon, it would possible to cover more than 83 % of all possible amino 
acid changes. In addition, ideal method would be  exible in bias generation e.g. avoiding 
disruptive amino acid substitutions or stop codons, distribute mutations evenly throughout 
the gene and have controllable mutation frequency (reviewed by Shivange et al., 2009; 
Wong et al., 2006; Wong et al., 2007b). All of the techniques in the vast array of random 
mutagenesis methods vary in terms of nucleotide mutational bias and amino acid substitution 
pattern, distribution of speci  c sequences in the library (ampli  cation bias), controllable 
mutation frequency, dependency on gene length as well as in their technical simplicity and 
robustness (reviewed by Neylon, 2004; Shivange et al., 2009; Wong et al., 2006; Wong et 
al., 2006; study I).
Recent advances in random mutagenesis methods overcome the challenge of 
substituting consecutive nucleotides (reviewed by Shivange et al., 2009). These methods 
include Sequence Saturation Mutagenesis (Wong et al., 2004; Wong et al., 2008), which 
employs terminal transferase for incorporation of universal bases and applications based 




Table 2 . Some of the most commonly used random mutagenesis methods resulting in one 
nucleotide changes
Techniques Description References
Chemical method Chemical methods incorporate DNA modifying 
agents or DNA analogues into DNA and introduce 
mutations by incorrect replication or repair.
Nitrous acid Myers et al., 1985
Formic acid Myers et al., 1985
Hydrazine Myers et al., 1985
Ethyl methane 
sulfonate, EMS






Cell-based method Mutagenesis in vivo is performed by transforming 
a plasmid containing the gene to be mutagenized 
to a mutator E. coli strain. These strains lack 
DNA repair mechanisms or contain a modi  ed 
polymerase with lower  delity.
E. coli expressing 
mutA allele
Miller, 1992 
E. coli XL1–Red 
strain expressing 
mutS, mutT, and 
mutD alleles
Greener et al., 
1996
E. coli expressing 
ep Pol I
Camps et al., 2003
Baldwin et al., 2008 and transposon integration mediated mutagenesis (TIM): Hoeller et 
al., 2008). Other powerful strategies to generate molecular diversity include recombination-
based methods. Homologous recombination methods recombine genes to form sequence 
diversity depending on homology and nonhomologous recombination methods without 
sequence homology (reviewed by Kumar and Singh, 2012). One of the most used techniques 
is DNA shuf  ing, which involves random fragmentation of a gene or a pool of homologous 
genes and recombination in a self-priming PCR reaction (Stemmer, 1994a; Stemmer, 1994b). 
In addition, to manage challenges in directed protein evolution studies several general 
theoretical concepts and computational programs are developed to equip protein engineers 




Error-prone PCR Genetic diversity introduced by inaccurate 
duplication of genes by low-  delity polymerase 
and/or buffer conditions.










Taq-pol I614K Patel et al., 2001
Mutazyme I Cline et al., 1996
Mutazyme II Stratagene, 2004
Human X and Y 
family polymerases
Emond et al., 
2008
Pfu-Pol(exo-)D473G Biles and 
Connolly, 2004
Combined methods
EpPCR followed by 
8-hydroxy-dGTP 
and dPTP by Taq-
pol
Zaccolo et al., 
1996
EpPCR followed by 
8-oxo-dGTP mRNA 
mutagenesis by Q  
replicase
Kopsidas et al., 
2007
Ep rolling circle 
ampli  cation
Fujii et al., 2004
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2 AIMS OF THE STUDY
This work focuses on the functional characterization of Mu transposition machinery. Despite 
the wealth of knowledge of the biochemistry of Mu transposition, little detailed structure-
function information is available on the Mu transposition machinery or the determinants 
that govern the transposition ef  ciency of the Mu system. The aim of this study was to 
characterize the MuA transposase protein structure-function relationships and to modify 
MuA transposase for increased transposition ef  ciency with the objective of improving 
Mu in vitro transposition applications. For these purposes, it was essential to determine the 
random DNA mutagenesis conditions suitable for MuA protein engineering and to establish 
an in vivo assay for quantitative analysis of transposition. 
The speci  c aims were:
1. To critically evaluate and compare different random mutagenesis methods. 
Determine their mutation parameters, controllable mutation frequencies, mutation 
spectra, and amino acid substitution patterns.
2. To develop a universal and adjustable in vivo assay for the quantitative analysis 
of DNA transposition and to design the assay to mimic the minimal Mu in vitro 
transposition reaction. 
3. To quantitatively analyze the structure-function relationships of MuA transposase. 
Differentiate between the structurally and functionally important regions within the 
MuA protein that are non-modi  able against those that are modi  able.
4. To generate MuA transposase variants with altered transposition frequencies. 
Characterize their hyperactivity-inducing properties in the context of the Mu 
transpososome. Generate MuA variants for different Mu-based applications.
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3 MATERIALS AND METHODS
The bacterial strains, plasmids, and oligonucleotides used in this study are described in 
the original publications. The experimental methods used in this study are described in the 
original publications and listed in Table 3. References to published methods can be found in 
the articles.
Table 3. Methods used in this study
Method Described and used in
Agarose gel electrophoresis techniques I, II, III, IV




DNA sequencing and sequence analysis I, II, III, IV
Electroelution I, II, III, IV
Error prone PCR I, IV
FPLC IV
HPLC IV
In vitro transposition reaction III, IV
In vivo transposition assay II, III, IV
Light microscopy II, III, IV
Molecular cloning techniques I, II, III, IV
PCR I, II, III, IV
Plasmid DNA isolation I, II, III, IV
Protein expression in bacteria II, IV
Protein puri  cation IV
Restriction analysis II
SDS-PAGE II, IV
Site-speci  c mutagenesis IV





4 RESULTS AND DISCUSSION
4.1 Mutant library genera  on for protein structure-func  on 
studies (I, III, IV)
4.1.1 Random DNA mutagenesis methods (I, IV)
There is a myriad of random mutagenesis methods, which differ in their performance 
characteristics (reviewed by Jäckel et al., 2008; Kaur and Sharma, 2006; Neylon, 2004; 
Shivange et al., 2009; Wong et al., 2006; Yuan et al., 2005b; chapter 1.4). As the quality 
of mutant library is critical to the success of directed protein evolution experiment, an 
appropriate mutagenic method and speci  c mutagenic conditions for a particular purpose 
should be found. Although there are critical reviews and computer programs helping this 
task, they are based on several independent studies, not on direct comparisons. 
For MuA transposase protein engineering purposes and to aid of all protein engineers, 
we critically evaluated the important performance criteria for the most widely used random 
mutagenesis methods in the main mutagenesis categories. We varied critical mutagenic 
conditions and determined relative characteristics for error prone PCR with Taq DNA 
polymerase in low-  delity buffer condition and with a combination of nucleotide analogues 
(8-oxo-dGTP and dPTP), error prone PCR with Mutazyme II DNA polymerase using 
variable amount of amplicon and PCR cycles, XL1-Red mutator strain, and a chemical 
mutagen NH2OH-HCl. Our results provide easy to use guidelines for various DNA 
mutagenesis projects.
4.1.1.1 Visual assay allows convenient means to compare random 
mutagenesis methods (I)
The properties of the mutagenesis methods were speci  ed using an E. coli blue/white 
screening assay based on the enzymatic activity of -galactosidase (reviewed by Miller, 
1992). This assay allowed a visual and direct comparison of the methods in their operational 
ranges. We used as mutational target a gene fragment carrying lacZ , which encodes 
-complementing peptide of -galactosidase. When transformed into a host carrying 
N-terminal deletion of lacZ, -peptide complements the defective activity of the host 
lacZ gene product and forms the basis of blue/white screening. When bacteria containing 
mutagenized reported plasmid library were plated on indicator plates containing X-gal/
IPTG, original (or noncritically mutated) plasmids yield deep blue colonies. Plasmid clones 
harbouring critical mutations with regard to the reporter system, generate white or pale 
blue colonies. Therefore, the mutation frequency and controllability of a chosen method 
was determined by the proportion of discernible mutant colonies from the total number of 
colonies. Although the assay scored only mutant plasmid colonies containing mutations that 
alter lactose utilization, the proportion of discernible mutant colonies can be considered as a 
quantitative measure for relative mutation frequencies. 
Sequencing was used to analyze the number of mutations along the target sequence in 
the selected plasmid clones. The number of mutations detected by sequencing correlated 
well with the relative mutation frequencies. We included MuA gene into the mutational 
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gene target fragment. This allowed speci  c mutation types and amino acids changes to be 
determined along a longer region of protein-encoding DNA. In addition, we were able to 
simultaneously generate random mutations into a MuA gene encoding MuA transposase. 
4.1.1.2 Error prone PCR allows widely controllable mutation frequencies (I)
The mutation frequencies were determined from homoduplex mutant plasmid DNA libraries 
by evaluating approximately 1 × 104 colonies according to their colour for each of the 
mutagenesis method. Error prone PCR protocols proved to be powerful mutagenesis methods 
with widely controllable mutation frequencies. The relative mutation frequencies observed 
ranged from 2% to more than 90% when different error-prone PCR mutagenesis methods 
and various parameters were used (Figure 2 and 4 in I). In the nucleotide level, these speci  c 
mutagenic conditions can be used to generate mutant libraries containing 1 to more than 30 
mutations within the 1000-bp target gene. Taq DNA polymerase with either mutagenic buffer 
or nucleotide analogues 8-oxodGTP and dPTP was the most ef  cient mutagenesis method. 
When the goal is to generate simultaneously many mutations, Taq DNA polymerase with 
nucleotide analogues 8-oxodGTP and dPTP is a desirable protocol to be used. However, in 
protein engineering studies, the aim is commonly to cause one to four amino acid changes 
per protein (reviewed by Shivange et al., 2009). For these purposes other error-prone PCR 
protocols should be used. Even Taq DNA polymerase without mutagenic buffer proved to 
induce suf  cient number of mutations for many protein engineering projects. Error-prone 
PCR with Mutazyme II DNA polymerase allowed generation of mutant libraries of relatively 
low to moderate mutation frequencies. With the XL1-Red and NH2OH-HCl protocols the 
maximum achievable mutation frequencies were far from those obtained with error-prone 
PCR methods (2.0% and 0.31%, respectively). Regardless of the used mutagenic conditions, 
these methods are usable for obtaining only a few mutations into a long target gene. 
4.1.1.3 Random mutagenesis methods are biased to transitions (I, IV)
All current random DNA mutagenesis methods suffer from a bias towards transition 
mutations, in spite of the several efforts of compensating their occurrence (reviewed by 
Shivange et al., 2009; Wong et al., 2006). We determined by DNA sequence analysis the 
mutation spectrum and the different types of bias at the level of nucleotide mutations for 
all of the evaluated mutagenesis methods (Table 1 and III, Figure 3 and 5 in I). The number 
of clones analysed per mutagenesis method ranged from 15 to 27, and the total number of 
sequenced nucleotides varied between 12,000 and 21,000 per method.
Transition bias was prevalent among the methods analyzed. Taq DNA polymerase 
with nucleotide analogues and NH2OH-HCl protocols were the most biased methods and 
Mutazyme II DNA polymerase the least biased. With regard to bias between different 
transition mutations, Taq DNA polymerase was biased to A:T G:C and all the other 
methods to G:C A:T transitions. The bias among transversion mutation was commonly 
towards A:T T:A transversions. Mutazyme II DNA polymerase was the only method able 
to induce all types of mutations, also unwanted 1-bp insertions and deletions. Deletions of 
1 bp were detected also with Taq DNA polymerase protocols and XL1-Red mutator strain. 
The sequence analysis in study IV for MuA mutants generated by Taq DNA polymerase 
Results and Discussion
35
with mutagenic buffer protocol and Mutazyme II DNA polymerase with varying number of 
PCR cycles allowed supplementary validation and con  rmation of the mutational spectrum 
analysed (data not shown).
4.1.1.4 Amino acid substitution patterns (I, IV) 
Nucleotide mutations induced by a given mutagenesis methods influence the changes 
detected at the protein level. We evaluated the amino acid substitution patterns generated 
by the different error-prone PCR methods. We used compiled mutation data from the 
protein-encoding regions of the LacZ  sequence (60 amino acids) and C-terminus of the 
MuA sequence (143 amino acids) (Table 2 in I). The total number of amino acids analyzed 
varied among the different methods from approximately 3000 to over 4200. Mutations 
were distributed evenly along the target genes. Taq DNA polymerase with nucleotide 
analogues 8-oxodGTP and dPTP was the only method to produce consecutive nucleotide 
mutations, because of the high mutation frequency. Mutations were classi  ed into those that 
preserved the corresponding amino acid (silent mutation), changed it (missense mutation), 
or generate a stop codon (nonsense mutation). The differing preferences towards transitions 
versus transversions with Taq DNA polymerase and Mutazyme II DNA polymerase based 
methods caused differences also at the protein level. Taq DNA polymerase methods, which 
are more biased to transitions, preserved the amino acid more often than Mutazyme II 
DNA polymerase methods. This was in  uenced by the organization of genetic code, as it 
is optimized in the way that transitions lead often to chemically similar or identical amino 
acids (reviewed by Shivange et al., 2009; Wong et al., 2007a). Therefore, when produced 
amino acid changes were divided further to conservative and nonconservative substitutions, 
transition bias in  uence was obtained again. Mutazyme II DNA polymerase generated 
more detected nonconservative substitutions. However, when amino acid substitutions were 
analysed according to the change of chemical group, the different mutagenesis methods 
induced a very similar substitution pattern. This was detected also for the sequenced 
hyperactive MuA variants generated by Taq DNA polymerase and Mutazyme II DNA 
polymerase in study IV (Figure 3 and Supplementary Table 5 in IV).
It is considered that for successful protein engineering, it is important to avoid causing 
structurally interfering changes or stop codons (reviewed by Shivange et al., 2009; Wong 
et al., 2006). We analyzed the proportion of destabilizing amino acids substitutions such as 
glycine and proline as well as the stop codons. The total amount of these changes was similar 
with Taq DNA polymerase and Mutazyme II DNA polymerase. Because Mutazyme II DNA 
polymerase based methods yielded biases towards A and T nucleotides, they had a higher 
probability of generating stop codons. Correspondingly, Taq DNA polymerase methods were 
biased towards G and C nucleotides and generated more Gly codons and Pro codons. These 
structurally interfering glycine and proline changes were detected also for the screened MuA 
variants in study IV (Figure 3 and Supplementary Table 5 in IV). Generated proline residues 
were located in protein region not important for activity in the assay used. But many glycine 
residues generated improved activity. Therefore, too rational protein engineering may miss 
unexpected outcomes. One stop codon detected was proven to be leaking and allowed full 
length enzyme production (data not shown).
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4.1.2 Random MuA mutant plasmid libraries (IV)
The genetic variation generated in study I allowed us to choose gene libraries containing 
variable number and types of mutations within the MuA gene. A total of  ve different 
MuA mutant libraries were generated using Taq DNA polymerase under three mutagenic 
PCR conditions with 0, 1 or 2 l of mutagenic buffer and Mutazyme II DNA polymerase 
employing 5 and 10 cycles of ampli  cation. The resultant  ve mutant libraries included 
a total of ~3 × 105 independent plasmid clones (Supplementary Table 4 in IV). Of these 
libraries, 64,000 colonies were screened for enhanced activity (chapter 4.2.4.3). The amount 
of colonies exhibiting hyperactive phenotype ranged from 1.0% to 3.4% among protocols. 
Independent random mutant libraries generated with Taq DNA polymerase produced more 
hyperactive variants than with Mutazyme II DNA polymerase. In addition, the two clearly 
most hyperactive variants were from Taq DNA polymerase mutant library (Supplementary 
Table 5 in IV). Overall, both Mutazyme II DNA polymerase and Taq DNA polymerase 
protocols generated the same important amino acid substitutions in many critical positions. 
Commonly, transversions can introduce more variety into the mutant library. However, the 
compensation of transition bias with Mutazyme II DNA polymerase did not seem to affect 
MuA protein engineering results. These data indicated that the quality of random mutant 
libraries were high for protein engineering purposes. At the time we began this study, 
methods that introduce randomly consecutive nucleotide mutations in a codon were not in 
common use. Today, for example Mu in vitro transposition can be used to randomly replace 
amino acid residue to all possible counterparts (Baldwin et al., 2008). However, these kind 
of changes are commonly required if the intention is to derive new activities for a protein. If 
the aim is to improve the protein like in this study, subtle changes (caused by transitions) in 
protein sequence generally accomplish the task. 
4.1.3 MuA insertion mutant plasmid library (III)
Functional regions in proteins can be studied via transposition-assisted generation of libraries 
of linker insertion mutants (chapter 1.3.5.2). We decided to study MuA structure-function 
relationships using pentapeptide scanning mutagenesis (Poussu et al., 2004). We used Mu 
in vitro transposition reaction to introduce  ve amino acid insertions randomly throughout 
the MuA protein sequence. Initially, we generated a pool of plasmids each containing a 
transposon insertion within the MuA gene. Subsequently, we eliminated the transposon 
core sequence by digestion and recircularized the plasmid backbone to generate a pool of 
plasmids each containing only a 15-bp insertion within the MuA gene. The resultant MuA 
mutant plasmid library included a total of ~6 × 104 plasmid clones. The isolated plasmid 
DNA from 608 clones was subjected to restriction analysis to roughly map the 15-bp 
insertion sites. On the basis of the initial screen, a total of 331 clones were selected for 
insertion site mapping by DNA sequence analysis. From the large set of sequenced clones, 
a total of 233 clones with unique insertion site were identi  ed (Supplementary Table 1 in 
III). The overall distribution of insertion sites and their localization within the secondary 




4.2 Papilla  on assay –means to screen mutants (II, III, IV)
The success of protein engineering projects relies on the quality of mutant libraries and 
screening and selection strategies (reviewed by Kumar and Singh, 2012). Screening 
and selection methods should allow robust and high-throughput detection of even the 
comparatively slightly improved protein variants from the large mutant libraries. In order to 
monitor MuA mutants with altered transposition frequency, we needed a convenient assay to 
compare activities directly as well as quantitatively. 
There are several transposition assays developed in the past for in vivo analysis of 
transposition frequency (reviewed by Miller, 1992; Snyder and Champness, 2007). The 
most widely used method to study in vivo transposition is a visual colony screening assay 
also suitable for large-scale studies. This assay exploits the formation of coloured micro 
colonies or papillae within otherwise colourless bacterial colonies (Huisman and Kleckner, 
1987; Stellwagen and Craig, 1997b). Such papillation assays employ lac operon and 
utilize a reporter transposon including a promoterless lacZ gene (Derbyshire and Grindley, 
1996; Huisman and Kleckner, 1987; Krebs and Reznikoff, 1988; Lee and Harshey, 2001; 
Stellwagen and Craig, 1997b). Integration event into a genomic locus under the control of an 
active promoter would generate an active gene fusion and result in the expression of the lacZ 
gene. These events are detectable by the appearance of coloured Lac+ papillae on colourless 
Lac– colonies on appropriate indicator agar (Reznikoff et al., 1993). The number of 
papillae per colony is proportional to the frequency of transposition events catalysed by the 
transposase. This strategy has been used to study several host- (Makris et al., 1988; Swingle 
et al., 2004; Twiss et al., 2005; Weinreich et al., 1994), and element-encoded (Bender and 
Kleckner, 1992; Derbyshire and Grindley, 1996; Kim and Harshey, 1995; Lu and Craig, 
2000; Naumann and Reznikoff, 2002; Weinreich et al., 1994; Wiegand and Reznikoff, 1992) 
functions and transposon end sequences (Huisman and Kleckner, 1987; Lee and Harshey, 
2001; Makris et al., 1988; Tang et al., 1995; Tavakoli and Derbyshire, 1999) for a variety of 
transposons. However, all current papillation assays are element speci  c and do not allow 
quantitative or a broad dynamic range detection of transposition events.
We decided to exploit papillation for development of an easy-to-use method, which 
allows quantitative analysis of transposition frequency and is applicable to a variety of 
mobile DNA elements. These types of transposition assays are needed to characterize newly 
detected mobile elements as well as for methodology development of different transposons. 
4.2.1 Characteristics of the papillation assay plasmid (II)
Our aim was to set up a universal platform that is based on the transformation of E. coli 
with a single plasmid containing all the components required for transposon mobilization. 
First, we constructed the papillation assay plasmid, pLHH4, for phage Mu (Figure 1A in II). 
Important features of the papillation assay plasmid include (i) MuA transposase gene under 
arabinose/glucose-controllable PBAD promoter of E. coli and the expression unit bordered 
by strong transcription terminators, (ii) mini-Mu transposon containing N-terminally 
truncated E. coli lacZ ( 1-8lacZ) and cat gene between the 50-bp segments of Mu R-end 
DNA. Second, we modi  ed the papillation assay plasmid pLHH4, to be used as a universal 
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papillation plasmid cloning vector. In this modified papillation assay plasmid, pSKT1 
(Supplementary Figure 2 in II), Mu specific sequences were replaced by polylinkers. 
Therefore, straightforward directional cloning of any mobile element ends and a cognate 
transposase gene into the polylinkers enable adjustable in vivo transposition analysis of any 
speci  c DNA transposon system. These pBR322-derived plasmids exhibit medium copy 
number, and encode -lactamase. Two antibiotic selection marker genes prevent the growth 
of satellite colonies on plates emerging during long incubation period. In addition, marker 
gene within the reporter transposon may be useful feature in downstream applications.
4.2.2 Performance features of the papillation assay (II, IV)
The papillation assay is based on visual scoring of the transposition events. After 
transformation of the papillation plasmid into Lac– E. coli strain, several events lead to the 
quantitative analysis of transposition: (i) The expression of transposase protein results in 
the initiation of the transposition reaction. Transposase binds to the transposon ends and 
mobilizes the reporter transposon. (ii) When transposon is integrated into an expressed 
chromosomal gene in a correct orientation and reading frame it results in lacZ gene fusions 
and an expression of -galactosidase fusion protein. (iii) These events are detectable on 
the colour indicator plates after prolonged incubation by the formation of blue papillae on 
otherwise whitish colonies. A single papilla represents an individual transposition event. 
Our aim was to create assay conditions for a reliable and discernible papillae count. We also 
aimed to adjust the transposition frequency to a desired level via the control of arabinose 
promoter in the papillation plasmid. Standard papillation plates contained arabinose, X-gal, 
IPTG, and lactose.
4.2.2.1 Papillation characteristics
We evaluated different phenotypically Lac– E. coli strains including DH10B, DH5 , and 
JM109 for their suitability as a standard host in papillation assay (Table 1 in II). In addition, 
HT321 stain was evaluated as a low-papillation host. For the analysis, plasmid pLHH4 was 
transformed into various Lac– E. coli strains and colonies were grown on indicator plates with 
varying arabinose concentration for a reference time period. A number of critical attributes 
affecting the assay performance were evaluated, which proved to be strain-dependent. DH5  
strain formed large colonies with even distribution of papillae within a colony. Colonies of 
DH5  strain allowed scoring of more than 500 discernible papillae. In addition, the papillae 
number in DH5  strain was adjustable over a wide range of arabinose concentrations and 
was not signi  cantly affected by the total colony number on a plate. With regard to these 
aspects, DH5  strain was considered optimal for in vivo papillation assay. 
For further optimization and to verify the maximum dynamic range, plasmid pLHH4 
was transformed into DH5  strain and colonies were grown on indicator plates containing 
arabinose concentration of 0.1% at different temperatures: 22ºC (room temperature), 25ºC, 
30ºC, and 37ºC. Emerging papillae were enumerated as a function of incubation time 
(Figure 2 in II). At two higher temperatures large dynamic range was observed, but two 
lower temperatures were unable to produce reasonable maximum transposition. At the 
temperatures 30ºC and 37ºC, the papillae number increased linearly between the certain 
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time points. As incubation at 30ºC allowed more control to papillae formation, it was used 
in further studies as standard incubation temperature as well as 115 h as standard incubation 
time. However, lower temperatures may be required for stringent condition analysis of 
highly active transposase variants (Figure 7B and Supplementary Table 5 in IV).
4.2.2.2 Adjustability
The expression level of MuA transposase should impact the transposition frequency which 
is measurable by the number of papillae per colony. Initially, we examined the MuA 
expression levels under variable arabinose concentrations in liquid cultures. Subsequently, 
transposition frequency was studied under variable arabinose concentrations in papillation 
assay. The population-average protein expression levels of MuA analyzed by SDS-PAGE 
and Western blotting indicated that MuA expression levels were directly proportional to 
arabinose concentration up to 1 × 10-2% (Figure 3A in II). In papillation assay, papillae 
begun to be visible at ~1 × 10-4% arabinose concentration and continued to form up to 1 
× 10-1% arabinose concentration (Figure 3B in II). These results demonstrate that MuA 
expression level is induced by the arabinose concentration and correlates with a papillae 
number over a wide range of arabinose concentrations. It is known that at subsaturating 
arabinose concentrations gene expression from plasmids containing PBAD promoter result 
in mixed population of cells that are either highly induced or uninduced (Siegele and Hu, 
1997). Yet, a degree of transposase expression variation is present in the subpopulations, 
resulting in a controllable population level average expression of transposase by arabinose 
concentration. The adjustability of the transposition frequency allows assay to be used for 
different screening purposes.  For example, for the screen of more active mutants, the wild 
type activity level is adjusted to yield only a few papillae per colony (IV). 
Glucose can be used to add another level of control to transposase expression. PBAD 
promoter was observed to allow some basal expression of transposase. If uninduced 
transposase expression results in a high papillae number, glucose can be added onto growth 
medium to reduce the papillae number to a desired level (see below).
4.2.3 Universal platform (II)
The aim was also to develop the assay to applicable for other mobile DNA elements. 
We veri  ed the universality of the assay by cloning of the critical components of IS903 
transposition system into the universal papillation assay cloning vector pSKT1. This 
papillation assay plasmid of IS903 was transformed into DH5  cells and analysed for 
papillation in standard assay conditions under varying concentrations of arabinose. High 
transposition frequency was observed for the natural IS903 system, even without arabinose 
induction. The addition of glucose at varying concentration allowed transposition frequency 
to be adjusted linearly (Figure 6 in II). Therefore, the papillation assay established could be 
used for in vivo transposition analysis also for other transposition system. Although Mu and 
IS903 both use replicative transposition, we presume this papillation assay to be used for 
other types of transposable elements as well.
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4.2.4 MuA mutant screening in papillation assay (II, III, IV)
The primary aim in the papillation assay development was to provide means to screen and 
scrutinize different types of MuA transposase variants, also potentially usable for Mu in 
vitro transposition applications. Therefore, the assay was designed to mimic minimal in vitro 
reaction as closely as possible. Accordingly, reporter transposon contained only 50-bp of 
Mu R-end in each transposon end. The system omitted the known auxiliary factors of Mu 
transposition, such as the transposition enhancer and activator/targeting protein MuB. The 
assay scores only fully productive transposition events and allow reliable assessment of 
determinants affecting transposition.
4.2.4.1 Different MuA activities can be quantitatively analyzed in papillation 
assay (II)
Our aim was to test the assay under different levels of transposase activity and thus verify 
applicability of the assay as a screening method in protein engineering studies. We examined 
in the papillation assay various deletion variants of MuA previously scrutinized in vitro 
conditions (Baker et al., 1991; Clubb et al., 1996; Leung and Harshey, 1991). We used 
an N-terminally deleted MuA77-663 and C-terminally deleted variant MuA1-615 as well as a 
variant missing both termini MuA77-615. In addition, DDE-triad mutant MuAE392Q, which 
is pro  cient for the transpososome assembly but catalytically defective, was used (Baker 
and Luo, 1994). MuA variants were analyzed under varying arabinose concentrations with 
standard papillation condition 30ºC, 115 h (Figure 4 and Figure 5 in II). The assay allowed 
activities above and below the wild type level to be reliably detected. N-terminal variant was 
hyperactive, DDE-triad mutant inactive, and C-terminal deletion containing proteins were 
hypoactive. The papillation assay lacks the auxiliary transposition factors enhancer sequence 
and MuB protein, which are bound by subdomains I  and III , respectively. When the same 
transposition factors are omitted in vitro, subdomains I  and III  are not essential for the 
transposition reaction (Kim and Morrison, 2009). In the enhancer independent conditions 
subdomain I  have even been shown to be somewhat inhibitory (Mizuuchi and Mizuuchi, 
1989; Yang et al., 1995) and under these conditions deletion of the subdomain I  has induced 
hyperactivity (Clubb et al., 1996; Kim and Morrison, 2009). However, the subdomain III  
is also bound by ClpX, which is required for transpososome disassembly. Inability of this 
function conceivably causes hypoactivity in vivo. Overall, results demonstrated that Mu 
transposition can be reproduced with minimal components also in vivo. Most importantly, 
the assay proved to be sensitive for advanced screening purposes. 
4.2.4.2 Broad range of activities among insertion variants of MuA (III)
MuA insertion variants generated by pentapeptide scanning mutagenesis were analyzed 
in standard papillation conditions at 30ºC for 115 h with arabinose concentration of 0.1%. 
Under these conditions, wild type MuA produces ~200 papillae in a colony. Therefore 
activities above and below a wild type level are easily detected.  Insertion variants exhibited 
a broad range of activities in papillation assay (Figure 3 and Figure 4 in III). Most of the 
insertions reduced the MuA activity and even more than half of the insertion variants (125 
of 233) were totally inactive with no papillae produced. However, many mutants (36 of 233) 
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had an activity close to wild type (activity level 70 -130 %) and some insertions variants 
(12 of 233) had activities clearly above the wild type level. Even two-fold activity over 
the wild type level was observed. Results indicated that in general pentapeptide insertions 
signi  cantly interfere with the protein structure and/or function. However, certain regions in 
MuA protein allow insertional modi  cation.
4.2.4.3 Random mutations in MuA can induce hyperactivity (IV)
Different random MuA mutant libraries were screened for hyperactive MuA variants in 
papillation assay conditions at 30ºC for 115 h with arabinose concentration of 1 × 10-4%. 
Under these conditions, wild type MuA produces ~10 papillae in a colony and allows 
straightforward detection of different types of hyperactive variants. A total of 64,000 
colonies were screened by visual inspection. A large set of clones portraying a high activity 
phenotype were selected for further scrutiny. The 89 plasmid clones, which clearly induced 
a substantially elevated MuA speci  c level of papillation, were subjected to quantitative 
papillation analysis under stringent conditions (at 25 oC for 140 h). In addition, their MuA 
sequence was determined and translated to reveal changes at the amino acid level. A total of 
72 unique sequences were identi  ed, and most of these sequences contained several changes 
(Supplementary Table 5 in IV). The variants portrayed a broad spectrum of hyperactivity, and 
a correlation with speci  c amino acid changes was apparent (Figure 3 and Supplementary 
Table 5 in IV). Certain mutations were identi  ed frequently and special hot spots could be 
discerned. As these mutations were generated independently in different libraries their role in 
causing hyperactive phenotype was proposed. In contrast, many changes that were identi  ed 
only once were supposedly irrelevant for the hyperactive phenotype. The results suggested 
that the screen used was sensitive and effective in revealing hyperactivity-causing mutations.
To dissect the potential mutations causing hyperactivity phenotype, we generated single-
substitution MuA variants. We included changes that were present in several independent 
clones or present in an individual clone yielding extremely improved activity. In addition, 
we wanted to study mutations located in all of the separate subdomains. A total of 47 single 
substitutions in 35 different amino acids were generated and their the transposition activity 
was quanti  ed in papillation assay (at 30 ºC for 115 h with arabinose concentration of 1 ×10-
4%) (Figure 4 in IV). We identi  ed 34 substitutions in 27 speci  c amino acid residues, which 
enhanced the protein activity at least two-fold. The highest activity detected was 50-fold 
over the wild type level. This indicated that we were able to  nd the particular residues 
and speci  c changes in them that resulted in hyperactivity from the large set of mutants. 
Although mutant libraries produced by error-prone PCR cannot contain an exhaustive 
mutant repertoire, every residue in the protein was subjected to a change. We suppose that 
most of the amino acids in MuA protein sequence potential to cause hyperactivity phenotype 
were detected. 
The highest papillation activities were detected for screened variants containing 
multiple substitutions. Therefore, it was evident that several activity-improving substitutions 
can be combined to yield synergistic effects on the transpositional activity of MuA. To 
scrutinize synergism, various mutation combinations were generated with the important 
amino acids contained in the most active variant identi  ed in our screen (clone EP3I4) 
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(Figure 7, Supplementary Table 5 and 6 in IV). Of the  ve amino acid substitutions, three 
improved activity as single-substitution variant and were combined. Triple-substitution 
mutant (W160R, W345R, M374V) portrayed the highest activity reaching that of the 
original variant. To further validate the effect of various mutation combinations M374V 
was changed to E233K. This variant containing mutations in three different subdomains 
was the most active variant and produced over 500 times more papillae than wild type MuA 
(Supplementary Table 6 in IV). The data suggest that  nding a special combinations of 
different mutations yield high activities due to synergism, an effect that has also previously 
been reported in other transposase protein engineering studies (Goryshin and Reznikoff, 
1998; Lampe et al., 1999; Mates et al., 2009; Yusa et al., 2011; Zayed et al., 2004).
4.3 MuA structure-func  on rela  onships (III, IV)
We used two different approaches to study MuA protein structure-function relationships 
and to generate more ef  cient MuA transposase variants. Both of the methods used for 
mutant library construction, random mutagenesis and pentapeptide scanning mutagenesis, 
are straightforward strategies for library construction without the requirement for structural 
information of the protein. At the time we started this work, detailed structural information 
was available only for the separate subdomains of domain I and II. However, the recently 
resolved Mu transpososome structure with Mu R-ends and including target DNA allowed us 
detailed architectural probing of the functional data acquired by in vivo papillation analysis. 
The combined structure-function analysis forms a platform for further rational protein 
engineering.
4.3.1 Insertion tolerant versus intolerant regions within MuA 
domains (III)
The correlation of the activities of the 233 MuA insertion variants with the MuA domain 
structure (Figures 3–5 in III) produced a comprehensive map of insertion tolerant versus 
insertion-intolerant regions in the MuA protein. We observed clear differences in insertion 
tolerance between the separate subdomains of MuA (Figure 3 in III). The terminal 
subdomains I  and III  of MuA allowed insertions well. In contrast, subdomains I  and 
III  appeared to be entirely insertion-intolerant. Other subdomain I , II , and II  tolerated 
only some insertions in certain con  ned regions. A high degree of malleability (wild type 
level of activity or more) was detected for inter-domain linker connecting I  to I  and in 
certain loops (I : aa 126–130; II : aa 280 and aa 474–479) connecting secondary structural 
elements (Figure 5 and Figure 6 in III). Also several other loop regions allowing insertions 
with reduced activity were detected. For further validation of the quantitative functional data, 
we produced a protein sequence alignment for 44 members of MuA family transposases. In 
essence, the two separate data sets revealed the same modi  able regions in the MuA family 
members (Figure 6 and Figure 7 in III).
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4.3.1.1 Effects of insertions in the functional core of Mu transpososome
Our analysis revealed that the structure of MuA does not easily allow insertional 
modi  cation. Apart from terminal subdomains of MuA, the only allowed insertions were in 
loops or at the ends of secondary structural elements. This was consistent with the general 
scenario of insertion accommodation: Insertions are commonly accommodated on protein 
surfaces and in mobile protein regions. Inside of the protein core, amino acid chain extension 
is tolerated if it does not severely distort the protein structure (Heinz et al., 1994). Function 
of MuA is especially susceptible for structural rearrangements as it functions as a tetramer 
in the context of a large protein-DNA complex. There are several functions assigned for 
the MuA in the transpososome. In addition, protomers of MuA tetramer have separate 
roles when bound to R1 sites versus R2 sites of the transposon ends. The insertion variants 
were analysed in the papillation assay, which measures the outcome of the transposition. 
Therefore, the insertions had to be tolerated in each of the protomers within the tetramer. 
The insertion tolerance of subdomains I  and III  was consistent with the results 
derived with N- and C-terminal deletion variants in the papillation assay (chapter 4.2.4.1). 
Most of the indels found in the sequence alignment data of protein homologues were also 
in these regions. Results suggest some degree of malleability in their functions. Because 
subdomain I  is a DNA-binding module, distortion of this activity under conditions where 
the speci  c binding is not possible may improve the activity via inhibition of nonspeci  c 
DNA binding events. Correspondingly, insertions to the linker between I  and II  may allow 
subdomain I  to be moved further away causing less interference.
In contrast to enhancer binding, the recognition and speci  c DNA binding to transposon 
ends via subdomains I  and I  is fundamental for the activity. Accordingly, stringency in the 
architectures of these domains was detected (Figure 5 in III). Subdomain I  did not tolerate 
insertions within its DNA-binding surface or in the structures anchoring the recognition 
helices and subdomain I  was entirely insertion intolerant. In addition, insertions into the 
linker region between the domains suggested to bind to the DNA minor groove almost 
totally abolished the activity. High sequence conservation has been shown for these domains 
(Monta o et al., 2012). Same conservation was revealed by our combined data from the 
structure-function analysis and protein sequence alignment. Because the subdomain I  has 
also several other important protein-protein and protein-DNA contacts in transpososome 
when bound to R1 subunit, any structural perturbation to this helix bundle has to be 
functionally compromised. 
High conservation for the RNase H-like fold and the catalytic core was detected (Figure 
5 and Figure 7 in III). However, insertions into the loop residue aa 282 connecting  rst 
and second -strands of the RNase fold improved the activity. As this loop interacts with 
subdomain II , the enhanced activity is supposed to increase the  exibility between the 
subdomains of the catalytic core.  Another loop region (aa 474–479) allowing insertions 
with improved activity is in R2-bound subunit involved in protein-protein interaction with I  
domain of R1-bound subunit. The only allowed insertions to subdomain II  were in one loop 
tip (aa 529–531), which is not involved in target DNA capture. Mu transpososome structure 
revealed two separate roles for the long helix structure of subdomain III  when bound to R1 
versus R2 subunit. These functions were prevented by insertions into the helix, indicating 
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their essentiality for transposition. Generally, we propose that the allowed insertions in the 
inner MuA domains (I  to III ) were involved in the formation of favourable protein-protein 
contacts within the transpososome. 
4.3.2 Hyperactivity-inducing substitutions in MuA (IV)
The MuA mutant screen identi  ed 34 substitutions in 27 speci  c amino acid residues, 
which enhanced the protein activity at least two-fold (Figure 4 in IV). Although, most of 
these substitutions were in catalytic subdomain II , also all other subdomains contained 
at least one substitution enhancing MuA activity (Figure 5 in IV). The highest activities 
were detected for substitutions located in subdomains I , II , and II . The only enhancing 
substitution located in subdomain I  was A59V. It increased the protein activity to some 
extent (2.8-fold). As discussed previously (chapter 4.2.4.1) hyperactivity caused by 
mutations in I  supposedly weaken the disturbing nonspeci  c DNA binding in enhancer 
independent conditions. In subdomain I , two highly activating substitutions D97G and 
W160R are located in different helix structures not involved in DNA binding. The most 
active substitution and abundant in all mutant libraries was located in subdomain I . There 
were two different substitutions for this residue with different electrostatic changes, E233K 
and E233V. Other detected substitutions (E179A, E179V, D232N) in subdomain I  increased 
protein activity only slightly. Residues E233 and D232 are located in the turn/loop region 
following DNA recognition helix but not close to DNA. Residue E179 is located in the DNA 
minor-groove-binding linker region between I  and I . 
The most of the activating substitutions located in subdomain II  enhanced the activity 
more than 15-fold (Q254R, I335T, G340S, W345C, M374V, F447S, R478C, R478H, 
E482K, E483G, E483V, M487I). Also substantial enhancement was detected for several 
substitutions: E258G, G302D, W345R, M374T, F447Y, and F464Y. Two substitutions with 
only a slight activity increase were D320V and D466G. In domain structure of II , these 
residues can be divided to two regions, the one is the several loops and secondary structures 
surrounding DDE motif and the other is the loops and secondary structures on the surface 
on the other side of the domain. In subdomain II , two substitutions V495A and V507A 
enhanced activity extensively (14-fold and 26-fold, respectively) and two substitutions 
Q539H and Q539R moderately (5-fold and 6-fold, respectively). V495A and V507A and are 
located in -strands near the turn from II  that forms part of II . Residue Q539 is located in 
a helix also close to subdomain II .
One activating mutation was located in each of the separate subdomains of domain 
III. Substitution Q594R had 10-fold activity and I617T only 2.5-fold activity. Substitution 
Q594R is located at the end of a long helix structure of subdomain III  involved in DNA 
binding. The structure of subdomain III  has not been resolved and was not involved in 
the Mu transpososome crystal structure. Because, substitution of I617T is in the region 




4.3.2.1 Hyperactivity characteristics in Mu transpososome
Mapping of the hyperactivity-inducing substitutions into the Mu transpososome structure, 
offered us insights into mechanisms of hyperactivity. We were able to reveal several 
different protein-DNA and protein-protein interaction surfaces where mutations resulted 
in hyperactivity. In the Mu transpososome structure, hyperactivity-inducing mutations 
were found to locate in two different interface groups between R1-bound and R2-bound 
subunits. Many mutated residues were within the interaction surface between subdomains 
II  and I  (aa 97, 160, 478, 482, 483 and 487) (Figure 6C in IV). Substitution of residues 
to less negative or more positive in this interface may conceivably improve protein-protein 
interactions. Because subdomain II  has a structural role in this context, mutations may 
offer better stability for the structure. This region was found also in study III to result in 
hyperactivity via insertions. Another R1–R2 interaction group was detected for II  and III  
subdomains of R2 subunit sandwiching the turn/loop region following the recognition helix 
of I  domain (aa 232 and 233) of R1 (Figure 6C in IV). This interface contained the two 
most active substitutions of the same residue (E233K and E233V), indicating importance of 
the charge change in the protein-protein interface. This interaction has been proposed to be 
important as there is high sequence conservation for subdomain I  in MuA related sequences 
(Monta o et al., 2012; study III).
The hyperactivity-inducing substitutions in subdomain II  were close to the catalytic 
core (aa 302, 335, 340, 345, and 374) or packed against loops containing E393 and/or 
the adjacent loop interacting with non-transferred strand (aa 254, 258, 447, 464, and 466) 
(Figure 6D in IV). Because several of the substitutions close to active site changed the 
packing and  exibility properties of the affected residue the proposed effect was involved 
in packing of the core. Similarly, the loop containing E392 must change conformation for 
catalysis. Therefore, it is suggested that mutations close to that loop and/or the adjacent loop 
must be involved in conformational changes.
Improved DNA binding is assumed for two substitutions changing the electrostatic of 
the residue to more desirable for DNA binding. E179V in subdomain I  is close to Mu end 
DNA on R1 and R2, and close to the proposed  anking host DNA on R1. Correspondingly, 
substitution Q594R in subdomain III  is close to target DNA on R1 and the proposed 
 anking host DNA on R2.
Although substitutions in MuA structure can effect on general properties of the protein, 
improvement of the protein activity must also re  ect critical functional aspects. Particularly, 
multiple substitutions were localized to the same hyperactivity-inducing surfaces as well 
as were complemented by the insertional mutant data and the evolutionary component 
offered by sequence alignment of protein homologues. Therefore, we propose the activity 
enhancements are explained as being associated with DNA binding interactions, active site 
packing and conformational changes, as well as subunit-subunit interface associations. All 
these interactions have an effect in higher-order transactions, from assembly to structural 
transitions during the progression of transpososome development pro  cient for catalysis.
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4.3.3 MuA substitution mutants for application purposes
Hyperactivity-inducing substitutions and their activities were identi  ed using the in vivo 
papillation assay. Despite the assay was designed to mimic Mu in vitro transposition, it 
re  ects transpositional activity in vivo. For in vitro activity assessment, 30 single-substitution 
MuA protein variants and a triple mutant (W160R, E233K, W345R) were puri  ed and 
evaluated in Mu in vitro application settings (Figures 8 and 9, Supplementary Figures 2 
and 3 in IV). First, Mu in vitro transposition reaction was performed for each of the protein 
variants with precleaved mini-Mu transposon and pUC19 plasmid as a target DNA (Figure 
8A in IV). Second, Mu transpososomes were assembled in vitro in the absence of divalent 
cations. Following electroporation into E. coli cells, these complexes integrate transposon 
DNA into the host chromosomal DNA (Figure 9A in IV). Reaction products were analyzed 
qualitatively (Supplementary Figure 2 and Supplementary Figure3 in IV) by agarose gel 
electrophoresis and scored quantitatively by antibiotic selection on plates (Figure 8B and 
Figure 9B in IV). 
Most of the activities in both assays were above the wild type level but the scale of 
activities was narrower than detected in vivo. The most active single-substitution variant 
had activities up to 6-fold and 4-fold in two different assays. Similar activity reductions 
for in vivo screened hyperactive transposases have been detected in vitro also in other 
transposition systems (Lampe et al., 1999). The  rst assay resembles in vivo papillation 
assay as both emulate the entire transposition pathway. In this assay the activities of the 
puri  ed proteins mostly compared well to the relative activities detected in vivo. However, 
 ve variants harboring a mutation within a stretch of amino acids encompassing residues 
320-345 had a substantial reduction of activity compared to the activities detected in vivo. 
In the second assay, the activities of the puri  ed proteins differed more from their in vivo 
activites. In this assay, also the execution of the transposition pathway differs more from 
the in vivo papillation assay as the transposition is phased to seperate complex assembly 
and subsequent integration event. However, the amounts of complexes produced by various 
protein variants were consistent with the number of integration events. All the proteins 
except D320V were capable for transpososome assembly and intergration. Approximately 
two thirds of the proteins resulted in enhancements in genomic integration. The triple mutant 
(W160R, E233K, W345R), which portrayed hyperactivity in vivo due synergism generated 
synergistic activity also in vitro. 
Some of the differences between results of in vivo and in vitro assays can be explained 
by the oxidizing in vitro versus reducing in vivo conditions. Especially, substituted W345C 
may get oxidized under the in vitro assay conditions causing interference. The differences 
between results may also re  ect host factor involvement present in vivo but not in vitro 
conditions. As both assays were conducted with one protein preparation per each substitution, 
the quality of the preparation may affect in principle. We conducted protein gel analysis and 
nuclease assay as quality control measures, but other protein feature measurement should 
be performed to validate the results. However, as most of the protein variants behaved in 




Although, activity levels detected for puri  ed proteins in vitro were lower than in 
vivo conditions, the 6-fold and 4-fold activities detected in two different in vitro assays 
are signi  cant in many application purposes. Results indicate that to encounter the highest 
activity for separate in vitro applications, an application speci  c blend of mutations should be 
introduced in view to include all hyperactivity interfaces revealed in this study. In addition, 
to combine hyperactivity data from other studies such as deletion of N-terminal domain and 
including hyperactive insertions could produce a new level of activity improvement also in 




5 CONCLUSIONS AND FURTHER PERSPECTIVES
This study discovered important determinants with regard to the function of the Mu 
transpososome. Structure-function relationships in MuA action that were analyzed by 
different approaches describe a comprehensive global map of functionally important regions 
in MuA tetramer. The MuA protein engineering studies that were conducted provided a 
guide for developing successful directed evolution strategies. Initially, operational ranges 
of different commonly used random DNA mutagenesis methods and their corresponding 
mutation spectra were defined. The evaluations generated useful data for selecting a 
method(s) for the generation of diverse mutant libraries with controlled efficiency of 
mutagenesis and adjustment of mutation pattern(s). As subsequently established in vivo 
papillation assay provided the means to screen and scrutinize MuA transposase mutants 
sensitively and quantitatively. As a universal platform, in vivo papillation could be used to 
screen transposase mutants and genes that encode host factors for various mobile elements. 
It should also be applicable for mechanistic studies to dissect the transposition of novel 
element families yet to be discovered. 
A protein engineering approach that utilized different de  ned mutagenesis parameters 
for the generation of high quality MuA mutant libraries following effective in vivo 
papillation screening generated signi  cantly advanced MuA variants for various sets of 
Mu in vitro transposition based applications. The results suggested that MuA transposase 
did not evolve for maximal activity, even though it is the catalytic component of a virus. 
The highly active protein variants can be produced by mutating several residues and 
these substitutions generate excessive hyperactivity due to synergism. Therefore, speci  c 
mutation combinations should be found to create the most active protein variant for different 
applications.
Functional mapping by scanning mutagenesis combined with the sequence alignments 
of protein homologues yielded comprehensive data on insertion-tolerant versus insertion-
intolerant regions in MuA protein family members. In addition, combining the hyperactivity-
inducing substitution with the structural data revealed hyperactivity characteristics in 
Mu transpososome structure. Complementing the analysis with insertion-tolerant versus 
insertion-intolerant regions allowed further validation of hyperactivity-inducing properties. 
The results suggest the activity enhancements are associated with DNA binding interactions, 
active site packing and/or conformational changes, in addition to subunit-subunit interface 
associations. Several mutations in different protein-protein and protein-DNA interfaces 
include the catalytic core induced hyperactivity. Thus, these  ndings expand common 
knowledge with regard to the overall transpososome function and the architecture of the 
active site centre of MuA when assembled as a transpososome. All of the DDE-transposases 
share a common fold of the catalytic core and the active site. Consequently these results 
should be applicable to other members of this protein family. Attributes of the transpososome 
revealed in this study may be considered in future studies to improve the transpositional 
ef  ciency of a number of different transposable elements.
Conclusions and Further Perspectives
49
MuA was found to be a structurally  exible protein and modi  able in its functional 
features. This potentiates the use of a similar protein engineering strategy for altering 
target site selection of Mu transposition. In addition, other features revealed in this study 
are informative for future studies with regard to the function of the Mu transpososome. 
Combining the functional single substitution and insertion data with those of the structural 
data sheds light on the rational design of mutants with desired characteristics. Those sites 
that tolerate insertions could be utilized for different domain insertions including the DNA-
binding domain for targeted chromosomal integration, which is a desired feature in gene 
therapy applications. In general, produced hyperactive MuA transposase variants will 
improve MuA-based transposon tools and the knowledge gained from this study will enable 
novel tool design. In addition, an interesting question raised for future research is which of 
the protomers are critical with regard to particular insertion or amino acid substitution.
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